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Significant efforts over the past few decades have focused on engineering the common 
brewer’s yeast Saccharomyces cerevisiae to consume xylose, the second-most abundant sugar in 
nature.  Throughout these efforts, the goal has primarily been towards biofuels with ethanol as a 
target product.  This research revealed that many aspects of xylose metabolism in yeast are 
unfavorable for production of ethanol and substantial efforts have been directed towards 
enhancing yeast’s limited ability to produce ethanol from xylose.  With this narrow focus, many 
aspects of xylose metabolism have been overlooked which favor the production of non-ethanol 
compounds.  I present here a literature review of all compounds which have been produced from 
xylose using engineered S. cerevisiae.  Additionally, I will present personal research into 
developing engineering yeast strains capable of producing three compounds from xylose: 
isobutanol, sedoheptulose, and gadusol.  Finally, I investigate the benefits of xylose metabolism 
towards lactic acid production and show that simultaneous co-fermentation of glucose and xylose 
leads to enhanced lactic acid yields.  This work aims to highlight the benefits of xylose 
metabolism for many yeast metabolic engineering efforts and hopes to promote additional work 
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CHAPTER 1: THESIS INTRODUCTION 
 
1.1  Broad overview and background information 
Decades and billions of dollars have been invested towards bioethanol production from 
xylose using engineered yeast.  Despite these efforts, the rate of bioethanol production from 
xylose is still lower than the production of ethanol from glucose.  Adding on to this deficit, the 
yields of ethanol from xylose are also lower than from glucose.  Undeterred, many research 
efforts have continued beyond these setbacks towards the goal of realizing industrial bioethanol 
production from xylose.  In this time, the peculiarities of xylose metabolism leading to reduced 
rates and yields of ethanol have been viewed as difficult hurdles requiring unique and creative 
solutions.  Because of this perspective, many of these complications have been bypassed and the 
rate and yield of bioethanol production from xylose has been steadily rising.  However, this 
perspective on xylose metabolism and overall goal of bioethanol production has led many 
researchers to overlook a hidden benefit of xylose metabolism in engineered yeast: the 
production of non-ethanol compounds. 
Here, I will review the current research which has produced a variety of non-ethanol 
value-added bioproducts from xylose.  In many cases, the yields of these products have been 
higher than the yields from glucose.  In later chapters, I will present my research into the 
production of several compounds from xylose using engineered yeast.  By combining 
mitochondria-targeted isobutanol biosynthesis and heterologous xylose assimilation pathways, 
isobutanol is produced from xylose at higher yields and titers than observed from glucose.  Then, 
the rare seven-carbon sugar sedoheptulose is produced by overexpression of the broad-spectrum 
phosphatase PHO13 in engineered xylose-consuming yeast. These efforts lead to a maximum of 
25 grams sedoheptulose produced in a 1L bioreactor.  After observing the potential to direct flux 
towards rare seven-carbon compounds by employing xylose assimilation in yeast, I next show 
the production of the eight-carbon sunscreen molecule gadusol.  Xylose flux is directed towards 
sedoheptulose-7-phosphate, which is then cyclized and methylated to form the eight-carbon 
gadusol at titers over 250 mg/L. Finally, I will show the benefits of xylose metabolism for the 
production of lactic acid and partially recreate these benefits from glucose by reducing overall 
glycolytic flux.  The yield and titer of lactic acid is also improved by combining reduced 
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glycolytic flux with xylose metabolism, which leads to simultaneous consumption of glucose and 
xylose. 
 
1.2  Value-added biotransformation of cellulosic sugars into high-value products 
using engineered yeast 
A vast amount of research has gone into engineering xylose consumption into 
Saccharomyces cerevisiae.  Though the primary focus has been to produce bioethanol from 
lignocellulosic biomass, recent work has revealed an overlooked benefit of xylose metabolism: 
the production of non-ethanol target molecules.  This chapter is a literature review of all reported 
research to date using cellulosic carbon sources to produce advanced bioproducts. The various 
cellulosic biomasses as well as their sugar composition is reviewed in the first section.  Later, the 
production of acids, fuel alcohols, sugar alcohols, and isoprenoids are covered in this 
comprehensive literature review.  Along with each major product presented, a figure displaying 
the relevant metabolic pathways is also included. Finally, a comprehensive table is presented 
with the yields, titers, and literature references for every compound produced from xylose using 
engineered yeast. 
 
1.3  Bioconversion of xylose into isobutanol through yeast engineering 
Isobutanol is an advanced biofuel molecule with significant and growing interest as a 
potential economically viable bioproduct.  Substantial amounts of research have focused solely 
on engineering S. cerevisiae to produce isobutanol from xylose.  To this end, a large number of 
metabolic perturbations have been investigated to determine their effect on the production of 
isobutanol.  In this chapter, it is demonstrated that using xylose as a carbon source yields higher 
quantities of isobutanol than using glucose or galactose.  Expression of the isobutanol 
biosynthesis pathway is sufficient to observe this effect in engineered xylose-consuming yeasts 
and additional metabolic perturbations are not required.  In a fed batch fermentation, a maximum 




1.4  Microbial production of the rare sugar sedoheptulose 
There has been recent interest in rare sugars and sugar analogues for their potential 
sweetening capabilities while providing low to zero calories to the consumer.  Among them, the 
seven-carbon sugar sedoheptulose has recently emerged as an interesting compound for study.  
Recent studies have shown potential health benefits of this sugar as an anti-inflammatory and 
anti-diabetic agent.  Despite this, sedoheptulose is so prohibitively expensive that researchers 
aiming to study it perform plant extractions personally to isolate the sugar rather than purchasing 
it.  In this chapter, a method for producing sedoheptulose using engineered yeast is presented.  
By overexpression of the PHO13 gene and feeding of xylose, sedoheptulose is produced by 
dephosphorylation of sedoheptulose-7-phosphate.  Production yield and titer is later improved by 
deletion of the TAL1 gene, which directs much of xylose flux towards sedoheptulose production.  
At best, a yield of 0.4 g sedoheptulose / g xylose is achieved.  In a 1L bioreactor fed batch 
fermentation, up to 25 g/L sedoheptulose is produced. 
 
1.5  Producing the sunscreen compound gadusol through transgene expression in 
Saccharomyces cerevisiae 
A recent study identified the production of a sunscreen compound—gadusol—in Danio 
rerio, the zebrafish.  It was found that this compound is produced in two steps from 
sedoheptulose-7-phosphate.  After the previous chapter discovered that yeast can produce 
sedoheptulose in high quantities, this next research endeavor was begun.  Engineered xylose-
consuming yeast were transformed with the two enzymatic reactions in the gadusol biosynthesis 
pathway.  A set of strains was developed to analyze two variants for both the first and second 
steps in the gadusol biosynthesis pathway.  Gadusol production was detected by a unique 
absorbance peak in the UV spectrum.  Feeding of methionine showed that the second enzymatic 
reaction, which requires the methyl donor S-adenosylmethionine, was limiting the overall 
pathway.  By optimizing the pathway and feeding methionine, up to 250 mg/L gadusol is 
produced. 
 
1.6  Factors influencing lactic acid production by transgenic yeasts 
A number of studies have aimed to produce lactic acid from engineered yeast.  Among 
them, several have highlighted the benefits of using the cellulosic sugars xylose and cellobiose as 
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carbon sources instead of glucose.  When these alternative carbon sources are used for the 
production of lactic acid, ethanol production is reduced and lactic acid becomes the primary 
fermentation product.  One of the most identifiable differences between glucose metabolism and 
the metabolism of these alternative carbon sources is the rate of fermentation.  Glucose is 
consumed extremely rapidly while xylose and cellobiose are consumed comparatively slowly.  
To determine the effect of sugar consumption rate on lactic acid production, a set of strains with 
a controllable glucose consumption rate is constructed by deleting endogenous hexokinases and 
then reintroducing a single hexokinase under the control of a titratable promoter.  This strategy 
reveals that as the glucose consumption rate decreases, the lactic acid yield rises while the yield 
of ethanol drops.  This observation is used to explain the enhanced lactic acid yields from 
cellobiose.  Nonetheless, the yields of xylose cannot be explained by this phenomenon and it is 
concluded that some other physiological mechanism must contribute to the enhanced yields of 
lactic acid from xylose.  Finally, lactic acid is produced from a yeast strain capable of 
simultaneously consuming glucose and xylose.  By comparing to a parental strain which 
sequentially consumes glucose then xylose, it is shown that simultaneous co-fermentation of 






CHAPTER 2: VALUE-ADDED BIOTRANSFORMATION OF 





The substantial research efforts into lignocellulosic biofuels have generated an abundance 
of valuable knowledge for metabolic engineering. Among many advances in technology, these 
investments have led to a vast growth in proficiency of engineering the yeast Saccharomyces 
cerevisiae for consuming lignocellulosic sugars, enabling the simultaneous assimilation of 
multiple carbon sources, and producing a large variety of value-added products by introduction 
of heterologous metabolic pathways. While microbial conversion of cellulosic sugars into large-
volume low-value biofuels is not currently economically feasible, there may still be opportunities 
to produce other value-added chemicals as regulation of cellulosic sugar metabolism is quite 
different from glucose metabolism. This review summarizes these recent advances with an 
emphasis on employing engineered yeast for the bioconversion of lignocellulosic sugars into a 
variety of non-ethanol value-added products.  For each product covered in this review, the 
relevant metabolic biosynthesis pathways are presented along with the production titers and 
yields.  In some cases, the bioconverison of cellulosic sugars such as xylose and cellobiose led to 
increased yields and titers of the desired target products.   
 
 
                                                 
1 The contents of this chapter were published in the July 2018 issue of Bioresource Technology: 
 
Lane, Stephan, Jia Dong, and Yong-Su Jin. "Value-added biotransformation of cellulosic sugars 




2.1  Introduction 
Despite decades of intensive research and development, economic and sustainable 
implementation of a large-scale lignocellulosic ethanol industry has yet to be realized.  Many 
biofuel startup companies, such as Amyris, Terravia, and Ceres, have pivoted away from their 
original goal of biofuels and now focus on a wider range of value-added bioproducts (Lynd, 
2017).  Although the establishment of lignocellulosic ethanol has been more difficult than 
expected, the research investment has led to valuable innovations in metabolic engineering of the 
industrial workhorse strain Saccharomyces cerevisiae. 
Lignocellulosic feedstocks can be sourced from agricultural residues of crops farmed 
mainly for other purposes, such as corn stover or sugarcane bagasse, or alternatively from energy 
crops farmed primarily for their utility as a feedstock, such as Panicum virgatum (switchgrass) 
and Miscanthus x giganteus.  The majority of these crop’s biomass consists of cellulose, the β-
1,4 polymer of glucose; hemicellulose, a heteropolymer including glucose, xylose, arabinose, 
galactose, and other monomers; and lignin, a rigid polymer of organic alcohol monomers (Figure 
1, Table 1).  Glucose is the most predominant sugar in most lignocellulosic biomass, followed by 
xylose, then smaller quantities of other sugars (Figure 1, Table 2).  
The lignocellulosic bioconversion process can be broadly broken into two steps: 
hydrolysis of lignocellulosic biomass to produce monomeric sugars followed by fermentation of 
hydrolysates into desired products (Sun and Cheng, 2002).  Efficient hydrolysis processes are an 
on-going subject of research with a variety of proven methodologies including acid-based 
(Taherzadeh and Karimi, 2007), enzymatic (Van Dyk and Pletschke, 2012), thermal (Ma et al., 
2012), mechanical (Barakat et al., 2014), and multi-faceted combination processes (Subhedar 
and Gogate, 2013).  Merging the depolymerization and fermentation steps of lignocellulosic 
bioconversion has also been proposed in a process known as consolidated bioprocessing (Olson 
et al., 2012). 
Whichever methodology is chosen for depolymerization of feedstock, the robustness of 
the subsequent fermentation step will determine the efficiency and yields of product.  Substantial 
efforts have therefore been put towards engineering yeast to efficiently consume lignocellulosic 
sugars (Kwak and Jin, 2017), produce a large variety of value-added products (Borodina and 
Nielsen, 2014; Hammer and Avalos, 2017), and resist (Chen et al., 2016) or consume (Wei et al., 
2013) common fermentation inhibitors present in hydrolysates.  This review will cover the 
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technology allowing engineered yeast to consume lignocellulosic sugars efficiently and rapidly 
with a focus on the recent progress in value-added biotransformation of lignocellulosic sugars 
into a variety of non-ethanol products. 
 
2.2  Engineering lignocellulosic sugar consumption in yeast 
2.2.1 Xylose 
The isomerase and oxidoreductive pathways are two potential routes for engineering 
xylose assimilation into S. cerevisiae.  Each option comes with both benefits and drawbacks (X. 
Li et al., 2016). As such, the optimal pathway choice for strain design will depend on the 
intended application.  In both pathways xylulose is generated, phosphorylated by xylulose 
kinase, and metabolized in the Pentose Phosphate Pathway (PPP) (Figure 2A). 
The isomerase pathway consists of xylose isomerase (EC 5.3.1.5), which isomerizes 
xylose to xylulose, and xylulose kinase (EC 2.7.1.17) for phosphorylation of xylulose followed 
by further metabolism in the PPP.  Xylose isomerases from both fungi (Kuyper et al., 2005) and 
bacteria (Brat et al., 2009) have been functionally expressed in S. cerevisiae, although the top-
performing strains utilizing xylose isomerase employ isomerases of fungal origin (Lee et al., 
2014; Zhou et al., 2012).  Recently, expression of the Escherichia coli chaperones GroESL have 
been shown to improve functionality of a bacterial xylose isomerase expressed in yeast (Temer et 
al., 2017; P.F. Xia et al., 2016a, 2016b), leaving open the possibility that expression of bacterial 
xylose isomerases in yeast may be further improved and that additional optimizations may be 
required to achieve functionality on the level of fungal isomerases. 
The oxidoreductive pathway for xylose assimilation first reduces xylose to xylitol via 
xylose reductase (EC 1.1.1.21) with NADPH as a cofactor, followed by dehydrogenation of 
xylitol to xylulose by xylitol dehydrogenase (1.1.1.9) with NAD+ as a cofactor, and lastly 
phosphorylation of xylulose to xylulose-5-phosphate with xylulose kinase.  Genes from the 
xylose-consuming ascomycetous yeast Scheffersomyces stipitis (Liang et al., 2013; Papini et al., 
2012) have been widely used as a source for the oxidoreductive xylose consumption pathway 
and can be found in many of the top-performing engineered xylose-consuming yeasts employing 
the oxidoreductive pathway (Cadete et al., 2016; Kim et al., 2013). In contrast to the isomerase 
pathway, the oxidoreductive pathway requires two different cofactors – NADPH for xylose 
reductase and NAD+ for xylitol dehydrogenase – which can cause a cofactor imbalance.  In many 
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cases, this imbalance can lead to inefficient xylose assimilation and the accumulation of xylitol 
(Bruinenberg et al., 1984, 1983; Eliasson et al., 2000; Jin et al., 2000; Toivari et al., 2001).  
However, the cofactor imbalance can also be harnessed to drive useful reactions, such as the 
NADH-requiring acetate consumption pathway which can provide the NAD+ essential for xylitol 
dehydrogenation (Wei et al., 2015, 2013; Zhang et al., 2016).   Alternatively, mutant xylose 
reductases have been developed with enhanced preference for NADH to decrease the problems 
associated with cofactor imbalance (Bengtsson et al., 2009). 
One study directly compared the isomerase and oxidoreductase xylose consumption 
pathways in two top-performing engineered yeast strains (X. Li et al., 2016).  It was reported that 
the strain employing the oxidoreductase pathway consumed xylose faster, however the strain 
utilizing the isomerase pathway produced higher yields and titers of ethanol.  Thus, the 
isomerase pathway may be superior when high yields of ethanol are desirable.  On the other 
hand, strains employing the oxidoreductive pathway may be useful for non-ethanol products or 
with attempts to harness the cofactor imbalance for driving useful reactions. 
   
2.2.2 Arabinose 
Like the pathway transplantation used to enable xylose consumption, yeast can be 
engineered to assimilate arabinose through either a bacterial isomerase or fungal oxidoreductive 
pathway (Figure 2A).  The E. coli araBAD operon, consisting of L-ribulokinase (araB, EC 
2.7.1.16), L-arabinose isomerase (araA, EC 5.3.1.4), and L-ribulose-5-phosphate 4-epimerase 
(araD, EC 5.1.3.4), exemplifies the isomerase pathway and has been successfully expressed in 
yeast (Sedlak and Ho, 2001).  Alternatively, when one report was unable to detect any L-
arabinose isomerase activity from expression of E. coli araA, the Bacillus subtilis araA was 
successfully expressed in yeast (Becker and Boles, 2003), and the Bacillus licheniformis araA 
was found to further improve functionality in yeast (Wiedemann and Boles, 2008).  
The fungal oxidoreductive arabinose utilization pathway consists of an aldose reductase 
(EC 1.1.1.21), L-arabitol dehydrogenase (EC 1.1.1.12), and L-xylulose reductase (EC 1.1.1.10) 
followed by dehydrogenation to xylulose and phosphorylation as in the xylose consumption 
pathway (Figure 2A) (Bettiga et al., 2009).  Combining expression of an NAD+-dependent L-
arabitol dehydrogenase from Trichoderma reesei (Richard et al., 2001), an NADH-dependent L-
xylulose reductase from Ambrosiozyma monospora (Verho et al., 2004), a mutant aldose 
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reductase from S. stipitis with enhanced preference for the cofactor NADH (Bengtsson et al., 
2009), together with the S. stipitis xylitol dehydrogenase and xylulose kinase enabled 
assimilation of arabinose by engineered yeast (Bettiga et al., 2009). Again, the use of 
oxidoreductase pathway for arabinose assimilation in yeast will lead to the production of surplus 
NADH under anaerobic conditions. As such, the choice of pathway needs to be made with 
consideration for the cofactor balance of a heterologous pathway to produce a target product.  
 
2.2.3 Cellodextrins 
In contrast to the traditional method of hydrolyzing lignocellulosic biomass into 
monomeric sugars using expensive enzymatic processes, the concept of consolidated 
bioprocessing aims to decrease the requirements for depolymerization of biomass before usable 
in a fermentation (Hasunuma and Kondo, 2012; Nielsen et al., 2013; Olson et al., 2012).  
Enabling yeast to directly assimilate cellulose—the β-1,4 linked polymer of glucose—requires 
expression of proteins capable of enzymatic digestion of small fragments of cellulose 
(cellodextrins) into monomeric glucose, which can then be transported and phosphorylated for 
entrance into glycolysis (Figure 2B).  The simplest solution to this problem is the secretion of 
cellulases to extracellularly digest cellulose into glucose.  Making this option even more 
attractive is the decreased product inhibition in consolidated bioprocessing as opposed to 
pretreatment with enzymes.  During consolidated bioprocessing, the reaction is continuously 
driven towards depolymerization as glucose is consumed as it is generated.  Recent work has 
shown that engineered yeast at high cell densities are capable of producing cellobiohydrolases at 
concentrations above 1 g/L (Ilmén et al., 2011; Lee et al., 2017).  Further optimization of the 
production ratios of different cellulases also enhanced bioconversion efficiency (Liu et al., 
2017). 
Rather than secretion of cellulolytic enzymes, surface display of cellulolytic enzymes has 
also been explored.  Surface display is advantageous because glucose is immediately transported 
into the cell through high-affinity hexose transporters of yeast (Ozcan and Johnston, 1995; Özcan 
and Johnston, 1999).  Studies have shown that co-display of an endoglucanase and β-glucosidase 
allows conversion of cellulose to ethanol with a yield of 93.3% theoretical maximum (Fujita et 
al., 2002) and that yeast can maintain functional minicellulosomes along the cell periphery (Wen 
et al., 2010).  However, there is an increased metabolic burden associated with yeast surface 
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display as opposed to secretion (Ding et al., 2017), and a combined surface display and secretion 
strategy may prove to be more efficient than either secretion or surface display alone (Liu et al., 
2015). 
In contrast to the previous two technologies, where cellulose is hydrolyzed to glucose 
extracellularly followed by import of glucose into the cell, a third option has explored the 
expression of cellodextrin transporters coupled with intracellular hydrolysis into glucose 
monomers.  Cellodextrin transporters from a cellulolytic fungi Neurospora crassa have been 
proven to function properly when expressed in yeast (Galazka et al., 2010; H. Kim et al., 2014), 
allowing the intracellular transport of cellodextrin oligomers.  Subsequently, the cellodextrin 
oligomers can be intracellularly hydrolyzed into glucose followed by entrance to glycolysis.  
Intracellular depolymerization of cellodextrins is possible by either a β-glucosidase, which 
hydrolyzes β-1,4 linkages (Lee et al., 2013), or a cellodextrin phosphorylase. Cellodextrin 
phosphorylases may provide energetic benefits over β-glucosidase hydrolysis by separating a 
glucose monomer by insertion of an inorganic phosphate, producing a smaller cellodextrin and 
one glucose-1-phosphate without the use of ATP (Chomvong et al., 2014; Ha et al., 2013).  After 
conversion to glucose-6-phosphate by endogenous phosphoglucomutase encoded by PGM1, the 
resulting glucose monomer can then enter glycolysis.  Alternatively, there are also cellobiose 
phosphorylases with high activity for cellobiose (Ha et al., 2013).  In this case, expression of a β-
glucosidase would be required to digest cellodextrin oligomers into cellobiose, which could then 
be further hydrolyzed into glucose and glucose-1-phosphate. 
 
2.3  Simultaneous cofermentation of mixed sugars 
Lignocellulosic biomass is primary comprised of cellulose, hemicellulose, and lignin.  
After depolymerization and hydrolysis, mixtures of hexoses, pentoses, and often acetate are 
obtained.  Because of glucose repression of alternative carbon sources, engineered yeasts 
generally consume glucose before any other available carbon source (Conrad et al., 2014; 
Kayikci and Nielsen, 2015; Ye et al., 2014).  This leads to diauxic growth and two phases of 
sugar consumption:  rapid assimilation of glucose followed by slower consumption of other 
carbon sources (Farwick et al., 2014).  To avoid this problem, a variety of metabolic engineering 
strategies have been developed to enable simultaneous uptake of all available carbon sources. 
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In some cases, enabling cofermentation of multiple carbon sources is simple; Neither 
xylose nor arabinose repress consumption of the other, and thus can be co-consumed by 
simultaneous expression of both assimilation pathways (Bettiga et al., 2009; Caballero and 
Ramos, 2017; Sanchez et al., 2010).  Other times, however, expression of genes involved in 
assimilation of alternative carbon sources are repressed by complex interlinked signaling 
pathways (Conrad et al., 2014; Escalante-Chong et al., 2015; Kayikci and Nielsen, 2015) and 
may require deletion of key regulators (Bae et al., 2014) to enable simultaneous assimilation.  
For example, glucose repression of yeast GAL gene expression can be eliminated by deletion of 
HXK2 coding for the key regulator Hxk2p, allowing simultaneous uptake of glucose and 
galactose (Bae et al., 2014). 
Enabling simultaneous uptake of glucose and xylose has by far been the most difficult 
endeavor, with dozens of studies spanning over a decade investigating the mechanisms of 
repression and inventing new strain designs to bypass repression.  Initially, determination of the 
sugar transporter kinetics with regards to glucose (Reifenberger et al., 1997), and xylose 
(Saloheimo et al., 2007) coupled with their expression patterns in response to extracellular 
glucose (Ozcan and Johnston, 1995) allowed mathematical simulation of glucose and xylose 
cofermentation (Bertilsson et al., 2008).  The simulations indicated that xylose uptake would be 
strongly inhibited by the presence of glucose due to kinetic competition for transport, a fact 
which was later experimentally verified using a hexokinase-negative deletion mutant capable of 
transporting, but not metabolizing, glucose (Subtil and Boles, 2012). 
This kinetic inhibition of xylose transport necessitated the development or discovery of 
sugar transporters capable of simultaneously transporting glucose and xylose.  After the 
discovery of cellodextrin transporters functional in yeast enabled import and consumption of 
cellodextrin oligomers without complete depolymerization of cellulose to glucose (Galazka et 
al., 2010), cofermentation of xylose and cellobiose was demonstrated by expressing a 
cellodextrin transporter and intracellular β-glucosidase in an engineered yeast strain with the 
oxidoreductive xylose consumption pathway (Ha et al., 2011).  This strategy avoids the problems 
associated with glucose inhibition of xylose uptake by removing the need to completely 
depolymerize lignocellulosic biomass to glucose, and instead allowing partial depolymerization 
to cellodextrin oligomers.  Moreover, coupled cellobiose and xylose consumption enhanced rate 
and productivity of the entire fermentation (Ha et al., 2011). This result was later coupled with 
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acetate consumption (Wei et al., 2013; Zhang et al., 2016) to allow simultaneous cofermentation 
of cellobiose, xylose, and acetate which are three major fermentable carbon sources in most 
cellulosic hydrolysates (Wei et al., 2015). 
Afterwards, significant efforts were placed upon engineering transporters capable of 
importing xylose without glucose inhibition.  A conserved protein motif of the form G-G/F-
XXX-G in yeast sugar transporters was identified to play an important role in determining the 
sugar preference of transporters (Young et al., 2014).  By modifying this motif to enhance 
preference for xylose, the Vmax of xylose transport could be increased and the ability to transport 
glucose could be completely removed.  Nonetheless, glucose was still able to bind these 
modified transporters and inhibit the uptake of xylose (Young et al., 2014).  Later, a conserved 
critical asparagine residue (N376 in Gal2 and N370 in Hxt7) was found to mediate the binding of 
glucose to hexose transporters (Farwick et al., 2014). Mutating this asparagine to a nonpolar 
aliphatic amino acid (alanine, glycine, valine, leucine, or methionine) enabled growth on xylose 
with decreased or eliminated inhibition by glucose (Nijland et al., 2014). 
These findings led to renewed interest and a flurry of reports were soon published 
identifying additional mutant transporters capable of transporting xylose without inhibition by 
glucose.  A chimeric Hxt36 protein comprised of the first 438 amino acids of Hxt3 and the last 
130 amino acids of Hxt6 with an N367A mutation could transport xylose at a high rate with an 
improved affinity even in the presence of glucose (Nijland et al., 2014).  Evolution of the N. 
crassa xylose transporter AN25 led to identification of mutations S280G, 453C, A94T, E235G, 
F332S, T63A, and I299T which together improved cofermentation of glucose and xylose in 
engineered yeast, although it remains to be shown which mutations are essential for improving 
glucose/xylose cofermentation, which enhance stability or expression, and which are merely 
neutral (M. Wang et al., 2016).  Evolution and rational engineering identified the cryptic Hxt11 
transporter as capable of sustaining xylose transportation and mutation of the conserved N366 
residue enabled transport of xylose without inhibition by glucose (Shin et al., 2015).  The 
transporter Mgt05196 from Meyerozyma guilliermondii was functionally expressed in yeast and 
mutations F432A and N360S improved transport of xylose, while N360F removed glucose 
inhibition of xylose transport (Wang et al., 2015).  A F79S mutation in Hxt7 decreased glucose 
inhibition of xylose transport, although glucose and xylose were both co-transported (Apel et al., 
2016).  Evolution of the Candida intermedia glucose-xylose symporter Gxs1 (Leandro et al., 
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2006) led to identification of mutations N326H, I171F, M40V, and a truncation in the C-terminal 
tail as reducing glucose inhibition of xylose transport (H. Li et al., 2016) and allowing substantial 
transport of xylose in the presence of even high levels (70 g/L) of glucose.  Also, an evolved 
Gal2 transporter with L311R, L301R, K310R, N314D, M435T, and T386A mutations showed 
improved xylose affinity with decreased inhibition by glucose (Reznicek et al., 2015). 
Because yeast not only regulates expression levels of hexose transporters, but also 
internalizes and degrades non-optimal hexose transporters in response to extracellular glucose 
concentrations (Buziol et al., 2008; Krampe et al., 1998; Ozcan and Johnston, 1995), it is 
necessary to enhance the stability of engineered hexose transporters regardless of extracellular 
glucose concentrations.  The yeast hexose transporter Hxt11 is stable across a wide range of 
extracellular glucose concentrations (Shin et al., 2015), and thus one report aimed to confer this 
stability to Hxt2 through constructing a chimeric Hxt11/Hxt2 transporter as Hxt2 has greater 
potential for high-affinity xylose transport.  Because the glucose-induced degradation process is 
initiated by ubiquitination of lysine residues near the N-terminal end of hexose transporters (Roy 
et al., 2014), replacing residues 1-49 of Hxt2 with residues 1-54 of Hxt11 enhanced stability of 
Hxt2 (Shin et al., 2017).  Alternatively, it is possible to directly mutate the lysine ubiquitination 
sites to arginine residues, resulting in improved membrane localization and fermentation 
characteristics (Nijland et al., 2016).  
Most recently, it has been shown that reduction of the glucose phosphorylation rate 
enables the simultaneous consumption of glucose and xylose without any mutations to 
endogenous yeast transporters (Lane et al., 2018).  In this study, an engineered yeast strain 
expressing the oxidoreductive xylose assimilation pathway was repeatedly cultured in media 
containing xylose and the glucose analog 2-deoxyglucose, leading to isolation of a mutant 
capable of simultaneous glucose and xylose consumption.  Reverse engineering of the isolated 
strain revealed that the cofermentation phenotype was linked to mutations in HXK1, HXK2, and 
GLK1, the genes encoding the yeast glucose phosphorylation enzymes.  The cofermentation 
phenotype was then regenerated in the parental strain by varying the expression of wild-type 
hexokinases via doxycycline induction (Urlinger et al., 2000).  Interestingly, it was shown that 
reduction of the glucose phosphorylation rate also enabled simultaneous consumption of glucose 
and galactose.  However, consumption rates were reduced as compared to parental control strains 




2.4  Bioconversion of lignocellulosic sugars to non-ethanol products 
2.4.1  Xylitol 
In addition to ethanol, engineered yeast has been used in the bioconversion of xylose to a 
variety of other alcohols.  One notable example is the sugar-alcohol xylitol, the first intermediate 
in the oxidoreductive xylose consumption pathway (Figure 3), which is also used in the food 
industry as a low-calorie bulk sweetener (Kutyła-Kupidura et al., 2016; Rehman et al., 2017).  
Research efforts towards xylitol production from xylose in engineered yeast have led to near 
theoretically-maximum yields (Table 3).  An important aspect of xylitol production is that xylose 
flux is entirely directed towards the production of xylitol and cannot be used for cell growth.  
Consequently, it is necessary to co-feed another substrate to sustain cell growth and metabolism. 
Although glucose can be used as a co-substrate for xylitol production, the uptake of xylose is 
inhibited by glucose (Subtil and Boles, 2012), which can lead to decreased xylitol productivity 
(Oh et al., 2013).  As such, genetic and environmental perturbations have been developed to 
avoid glucose inhibition of xylose and achieve high productivities as well as near-maximum 
yields. 
Because xylose transport is inhibited by glucose due to the kinetic properties of hexose 
transporters (Bertilsson et al., 2008), this inhibition can be alleviated by having a xylose 
concentration much higher than the glucose concentration.  A glucose-limited fed-batch strategy 
for xylitol production led to high productivities and yields of xylitol from xylose (Jo et al., 2015).  
In the same study, the effects of the cofactor preference of xylose reductase were investigated.  
While xylose reductases exist with preference for either NADPH or NADH, it was found that co-
expression of both NADPH and NADH-preferring xylose reductase enzymes led to enhanced 
xylitol productivity and yield (Jo et al., 2015).  Additionally, ZWF1 coding for glucose-6-
phosphate dehydrogenase and ACS1 coding for acetyl-CoA synthetase were overexpressed to 
increase the pool of available NADPH and NADH, respectively.  Expression of NADPH and 
NADH-depended xylose reductases coupled with overexpression of ZWF1 and ACS1 in a 
continuous xylose-feeding strategy led to a xylitol productivity of 4.27 g/L•h.  Altogether, these 
methodologies led to a maximum production of 196.2 g/L xylitol (Jo et al., 2015).  A similar 
strategy attempted glucose-limited fed-batch production of xylitol by overexpressing ALD6 and 
ACS1 (Oh et al., 2012).  The dual overexpression of ALD6 and ACS1 aimed to redirect excess 
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acetaldehyde flux towards acetate, generating NADPH in the process, then to acetyl-CoA and the 
TCA cycle to enhance cell growth.  However, the best performance was seen with 
overexpression of ACS1 alone, leading to the production of 91.3 g/L xylitol at a maximum yield 
of 1 g xylitol/g xylose with a productivity of 1.76 g/L•h. 
In addition to glucose, S. cerevisiae can also consume glycerol as a carbon source.  
Making this substrate appealing is the fact that, unlike glucose, glycerol does not repress 
assimilation of xylose.  As such, there may be benefits to co-feeding strategies using xylose with 
galactose or glycerol.  Indeed, xylitol production while using glycerol as a co-substrate not only 
led to near-theoretical maximum yields, but also was superior as compared to glucose in the 
amount of co-substrate required to maintain adequate NADPH levels for xylose reduction.  This 
methodology led to a maximum production of 47 g/L xylitol (Kogje and Ghosalkar, 2017). 
However, although the observed yield of NADPH per mole of glycerol was higher than 
the observed yield of NADPH per mole of glucose, glucose can theoretically generate up to 12 
moles of NADPH per molecule.  Thus, it will be advantageous to use glucose as a co-substrate if 
strategies are developed to better harness the power of glucose for NADPH generation.  In order 
to bypass the glucose inhibition of xylose consumption, a strategy has been developed to express 
a cellodextrin transporter along with a β-glucosidase (Galazka et al., 2010; Ha et al., 2011).  Co-
expression of these two proteins allows the transport of cellodextrins and intracellular hydrolysis 
into glucose monomers.  Thus, no glucose exists extracellularly and xylose transport remains 
uninhibited.  When using this method, xylitol was produced to 93 g/L from mixtures of 
cellobiose and xylose, showed an improved yield as compared to glucose/xylose mixtures, nearly 
doubled the xylitol productivity, and enhanced cell growth (Oh et al., 2013).  By optimizing the 
expression of xylose reductase and the cellodextrin transporter, high-yield production of both 
ethanol and xylitol is possible (0.37 g/g and 1.0 g/g, respectively) (Zha et al., 2013).  As with 
engineering yeast to consume the glucose polymer cellobiose, yeast can also be engineered to 
uptake xylan, the β-1,4 polymer of xylose.  Through expression of a xylanase, β-xylosidase, and 
xylose reductase, yields of 0.71 g xylitol / g xylan were achieved with xylan as a carbon source 
and glucose as a co-substrate (Li et al., 2013). 
Efforts have also been put forth towards producing xylitol directly from cellulosic 
hydrolysates.  Using non-detoxified hemicellulosic hydrolysate of corncob as a carbon source, 
containing glucose and xylose at 7 g/L and 65 g/L respectively, xylitol yields approached the 
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theoretical maximum (Kogje and Ghosalkar, 2016) while glucose was continuously fed for 
NADPH regeneration after depletion of glucose in the original hydrolysate mixture.  
Additionally, engineered yeast expressing a xylose reductase and surface-displayed β-
glucosidase, xylosidase, and xylanase enzymes produced up to 37.9 g/L xylitol at a yield of 0.79 
g/g xylose directly from rice straw hydrolysate (Guirimand et al., 2016). 
Methods to enable simultaneous consumption of glucose and xylose have also been 
applied to xylitol production (Lane et al., 2018).  Glucose was used as a carbon source for 
cellular growth and maintenance while xylose flux was entirely directed towards xylitol.  By 
reducing the glucose phosphorylation rate, glucose repression on xylose uptake was alleviated 
and glucose was consumed at nearly the same rate xylitol was produced.  Thus, depletion of 
glucose occurred around the same time that xylose was completely converted to xylitol.  As 
compared to a control strain, the cofermenting strain produced xylitol faster and led to a higher 
titer of xylitol (21 g/L).  This strategy led to xylitol yields of around 1 g xylitol / g xylose. 
 
2.4.2  1-hexadecanol 
While xylitol is a simple and obvious example of a target product benefitted by using 
xylose as a carbon source, more advanced metabolic engineering efforts have also been applied 
synergistically with xylose consumption.  For example, yeast-based production of the fatty 
alcohol 1-hexadecanol, which has applications in detergents, emulsifiers, and cosmetics, was 
improved by coupling with a xylose consumption pathway.  Deletion of histone deacetylase gene 
RPD3 coupled with overexpression of ACC1 encoding acetyl-CoA carboxylase and Yarrowia 
lipolytica ATP-citrate lyase ACL enables production of 1-hexadecanol from glucose (Figure 4) 
(Feng et al., 2015).  When coupled with an optimized xylose consumption pathway, 1-
hexadecanol production was improved by 171%, producing 1.2 g/L 1-hexadecanol at a yield of 
0.1 g/g xylose, without any additional optimization of the 1-hexadecanol pathway (Guo et al., 
2016). 
 
2.4.3  Isobutanol 
Isobutanol is a promising biofuel and chemical, and it has been produced using xylose as 
a carbon source (Brat and Boles, 2013).  Coupled with an XI-XK xylose consumption pathway, 
overexpression of the isobutanol biosynthesis pathway (Figure 3) ARO10, ADH2, ILV2ΔN54, 
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ILV5ΔN48 and ILV3ΔN19 led to a small production of isobutanol to around 1.5 mg/L.  Although 
the yield and titer were quite low and a long way from commercial viability, little work was done 
on optimizing the xylose consumption and isobutanol production pathways in this study.  
Furthermore, recent demonstrations of enhanced isobutanol production through mitochondrial 
compartmentalization of the isobutanol production pathway (Avalos et al., 2013) coupled with 
the fact that xylose elicits a respiratory response in yeast (Jin et al., 2004) suggest the possibility 
for synergistic compatibility of xylose metabolism and isobutanol production. 
 
2.4.4  2,3-butanediol 
Several studies have produced engineered yeast capable of efficient production of 2,3-
butanediol (Figure 3), a molecule with applications in the plastics and fuels industries (Syu, 
2001), from lignocellulosic sugars.  Deletion of the pyruvate decarboxylase genes PDC1 and 
PDC5 with overexpression of the oxidoreductase xylose-consumption pathway, endogenous 2,3-
butanediol dehydrogenase BDH1, and the Bacillus subtilis 2,3-butanediol acetolactate synthase 
alsS and acetolactate decarboxylase alsD yielded up to 0.27 g 2,3-butanediol/g xylose at a 
maximum titer of 20.7 g/L in a batch fermentation (S. J. Kim et al., 2014; Seo et al., 2016).  
When using both glucose and xylose as carbon sources, the titer could be roughly doubled to 
43.6 g/L while the yield increased slightly to 0.29 g 2,3-butanediol/g sugar in a batch 
fermentation.  Later, production of 2,3-butanediol from xylose was enhanced by resolving the 
C2-compound auxotrophy of PDC deficient strains (S. J. Kim et al., 2017).  In this newer 
attempt, all three S. cerevisiae pyruvate decarboxylase genes (PDC1, PDC5, and PDC6) were 
deleted and Candida tropicalis pyruvate decarboxylase PDC1 was expressed.  While pyruvate 
decarboxylase-negative strains require supplementation of C2 compounds, expression of this 
heterologous PDC1 bypassed this dependency without directing large amounts of flux towards 
acetaldehyde.  Thus, the C2 compound auxotrophy could be resolved without high production of 
ethanol.  Next, the oxidoreductive xylose consumption pathway was expressed with an additional 
copy of a R276H mutant NADH-preferring xylose reductase.  TAL1 was also overexpressed to 
further improve xylose consumption efficiency.  These modifications with expression of yeast 
BDH1 and the B. subtilis alsS and alsD genes coupled with the Lactococcus lactis noxE gene 
encoding NADH oxidase increased 2,3-butanediol yields to 0.38 g/g xylose at a maximum titer 
of 69.2 g/L (S. J. Kim et al., 2017). 
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There have also been efforts to produce 2,3-butanediol from other lignocellulosic sugars.  
After introducing an intracellular β-glucosidase and a cellodextrin transporter with the 2,3-
butanediol production pathway alsS and alsD into a strain with deletion in pyruvate 
decarboxylases PDC1 and PDC5, the resulting strain produced 2,3-butanediol from cellobiose to 
about 5.3 g/L at a yield of 0.29 g/g (Nan et al., 2014). There are also two reports of 2,3-
butanediol production from mixtures of glucose and galactose.  In the first, pyruvate 
decarboxylase genes PDC1, PDC5, and PDC6 were deleted and growth on glucose was restored 
by expressing a mutant MTH1, a gene involved in the glucose signaling network with enhanced 
stability due to a truncation removing sites involved in protein degradation (Lian et al., 2014).  
The strain was then adaptively evolved in repeated glucose cultures to enhance glucose 
consumption ability followed by introduction of a 2,3-butanediol pathway consisting of a 
cytosolic acetolactate synthase cytoILV2, the B. subtilis acetolactate decarboxylase alsD, and 
overexpression of yeast butanediol dehydrogenase BDH1.  This strategy led to simultaneous 
conversion of glucose and galactose to over 100 g/L of enantiopure (2R,3R)-butanediol at yields 
of roughly 0.36 g / g sugar. The second paper followed a similar strategy with some 
modifications. First, PDC1 and PDC5 were deleted followed by introduction of a G241C mutant 
of the MTH1 gene. Following overexpression of yeast BDH1 and introduction of B. subitlis alsS 
and alsD, optimization of fermentation conditions and the ratio of extracellular glucose and 
galactose enabled production of 99.1 g/L 2,3-butanediol at yields of 0.35 g 2,3-butanediol/g 
sugar (Choi et al., 2016). 
As some carbon is lost to CO2, the theoretical maximum yield of 2,3-butanediol from 
xylose is 0.5 g/g (X. X. Wang et al., 2016). As such, the current level of production by 
engineered yeast is admirable yet still has significant room for improvement.  Engineered yeast 
strains cannot yet compete with natural producers of 2,3-butanediol, such as Klebsiella 
pneumoniae, which can reach near theoretical maximum yields (X. X. Wang et al., 2016), 
Nonetheless the GRAS status of S. cerevisiae, its enhanced tolerance to fermentation inhibitors 
compared to bacterial hosts, and the vast amount of knowledge accumulated about the species 




2.4.5  Lactic acid 
Surprising benefits have been found by combining consumption of lignocellulosic sugars 
with production of organic acids by engineered yeast. One striking example is found when 
engineering lignocellulosic sugar-consuming yeast to express a lactate dehydrogenase gene 
which converts pyruvate to lactic acid (Figure 3).  S. cerevisiae contains three strong pyruvate 
decarboxylase genes PDC1, PDC5, and PDC6 (Hohmann, 1991), which compete with a 
heterologous lactate dehydrogenase for pyruvate and result in higher production of ethanol than 
lactic acid (Colombié et al., 2003).  Overcoming this ethanol preference and redirecting the 
majority of flux towards lactic acid production has usually required reducing endogenous 
pyruvate decarboxylase activity through deletion or mutation (Adachi et al., 1998; Skory, 2003), 
which can have the unwanted and restrictive limitation of C2-compound auxotrophy (van Maris 
et al., 2004).  However, introduction of Rhizopus oryzae lactic acid dehydrogenase LdhA into a S. 
cerevisiae strain expressing the oxidoreductive xylose consumption pathway almost completely 
favored lactic acid production (producing 49.1 g/L lactic acid at a yield of 0.69 g/g xylose) over 
ethanol production (<0.01 g ethanol/g xylose) when cultured with xylose as a carbon source 
without any modification to the endogenous pyruvate decarboxylase genes (Turner et al., 2015).  
In contrast, the same strain cultured in glucose favored production of ethanol (0.31 g ethanol / g 
glucose) over lactic acid (0.22 g lactic acid/g glucose).  This result was later extended with a 
strain expressing both a cellobiose and xylose consumption pathway.  The LdhA-expressing 
strain with the oxidoreductive xylose consumption pathway, cellodextrin transporter CDT-1, and 
β-glucosidase GH1-1 simultaneously consumed cellobiose and xylose and produced 62 g/L lactic 
acid at a yield of 0.73 g lactic acid/g sugar (Turner et al., 2016).  When cultured on xylose, 
cellobiose, or a mixture of both, this strain favored production of lactic acid, while culturing on 
glucose favored production of ethanol. 
 
2.4.6  Poly-3-D-hydroxybutyrate (PHB) 
Xylose has also been used as a carbon source to produce poly-3-D-hydroxybutyrate, an 
organic acid useful for production of bio-based polymers.  In a strain overexpressing the 
oxidoreductive xylose consumption pathway and pentose phosphate pathway genes, the poly-3-
D-hydroxybutyrate production pathway from Cupriavidus necator was introduced consisting of 
acetyl-CoA acetyltransferase PhaA, acetoacetyl-CoA reductase PhaB1, and 
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polyhydroxylalkanoate synthase PhaC1 (Figure 5) (Sandström et al., 2015).  In an aerobic batch 
bioreactor, this strategy enabled production of 101.7 mg/L poly-3-D-hydroxybutyrate at a yield 
of 1.99 mg/g xylose.  In a later study, XYL1 was replaced with a mutant XYL1 (N272D) to 
enhance preference to NADH as opposed to NADPH, and the NADPH-preferring C. necator 
acetoacetyl-CoA reductase PhaB1 was replaced with the Allochromatium vinosum AAR which 
can use either NADPH or NADH as cofactors. The resulting strain produced at maximum 
252mg/L poly-3-D-hydroxybutyrate at a yield of 7.2 mg/g xylose in aerobic cultures while 360 
mg/L poly-3-D-hydroxybutyrate was produced at a yield of 7.0 mg/g xylose in anaerobic cultures 
(de las Heras et al., 2016). 
 
2.4.7  3-hydroxypropionic acid (3HPA) 
Xylose-based production of 3-hydroxypropionic acid, another building block for 
biopolymers, has also been demonstrated (Kildegaard et al., 2015).  Two potential pathways for 
production of 3-hydroxypropionic acid have been tested in engineered xylose-consuming yeast: 
the β-alanine and malonyl-CoA pathways (Figure 5).  In a strain containing the oxidoreductive 
xylose consumption pathway, the 3-hydroxypropionic acid production pathway consisting of two 
pyruvate carboxylase genes (PYC1, PYC2), β-alanine-pyruvate aminotransferase BAPAT from 
Bacillus cereus, Triboleum castanium aspartate 1-decarboxylase PAND, and the E. coli NADPH-
dependent 3-hydroxypropionate dehydrogenase HPDH.  The resulting strain produced 7.37 g/L 
3-hydroxypropionate at a yield of 0.17 g/g xylose in fed-batch fermentation.  In contrast, the 
malonyl-CoA pathway exhibited very poor production of 3-hydroxypropionate at a titer of only 
0.17 g/L when cultured on xylose. 
 
2.4.8  Glycolic acid 
Glycolic acid, a useful industrial compound with applications in cosmetics, chemical 
processes, and as a biopolymer precursor, has been successfully produced from xylose in 
engineered S. cerevisiae.  In one report, glyoxylate reductase GLYR1 from Arabidopsis thaliana 
was overexpressed in yeast expressing the oxidoreductive xylose consumption pathway to allow 
conversion of glyoxylate to glycolic acid (Figure 6) (Koivistoinen et al., 2013).  To increase the 
pool of available glyoxylate, malate synthase gene MLS1 and its homolog DAL7 were also 
deleted to prevent the formation of malate from glyoxylate and acetyl-CoA.  ICL1, which 
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produces glyoxylate from isocitrate, was also overexpressed in addition to a deletion in IDP2, 
which converts isocitrate to α-ketoglutarate and could potentially decrease the pool of isocitrate 
available for conversion to glyoxylate and then glycolic acid. Finally, REG1, which regulates the 
glyoxylate cycle in response to glucose, was deleted.  These efforts led to production of 0.91 g/L 
glycolic acid when cultured with 20 g/L xylose and 20 g/L ethanol (Koivistoinen et al., 2013).  A 
later study demonstrated production of either ethylene glycol or co-production of glycolic acid 
and lactic acid (Salusjärvi et al., 2017).  Through expression of XylB and XylD from Caulobacter 
crescentus enabled conversion of xylose to 2-keto-3-deoxyxylonic acid, which was then 
converted to glycolaldehyde and pyruvate by YagE or YjhH aldolase from E. coli.  Because the 
D-xylonate dehydratase encoded by XylD contained an Fe—S cluster which resulted in low 
activity when expressed in yeast, efforts were made to enhance its activity by tagging the protein 
with the mitochondrial targeting sequence of the yeast IDH1 gene or alternatively deleting the 
FRA2 gene, which may enhance the availability of Fe—S clusters in the cytosol.  While both 
strategies increased the D-xylonate dehydratase activity, mitochondrial targeting did not increase 
flux towards 2-keto-3-deoxyxylonic acid.  After these steps to optimize protein function to direct 
flux towards glycolaldehyde, it was observed that endogenous aldo-keto reductase allowed 
reduction of glycolaldehyde to ethylene glycol to maximum observed titers of 14 mg/L.  
Alternatively, expression of aldA from E. coli allowed conversion of glycoladehyde to glycolic 
acid to roughly 150 mg/L.  After expressing ldhL from Lactobacillus helveticus while aiming to 
co-produce glycolic acid and lactic acid (Figure 6), the titer of glycolic acid surprisingly 
increased to roughly 1 g/L after 96 hours of cultivation in a mixture of 10 g/L glucose and 20 g/L 
xylose (Salusjärvi et al., 2017). 
 
2.4.9  D-xylonate 
The organic acid D-xylonate, which has applications as a chelator, dispersant, antibiotic, 
and precursor in chemical synthesis, can be produced from D-xylose using a xylose 
dehydrogenase (Figure 3) (Toivari et al., 2012).  Expression of the T. reesei xylose 
dehydrogenase xyd1 gene in yeast led to production of 3.8 g/L xylonate at a yield of 0.4 g / g 
xylose.  This fermentation was performed in medium containing a mixture of glucose, xylose, 
and supplementation with ethanol late in fermentation, which provided energy for the oxidation 
of xylose without inhibiting the uptake of xylose.  Deletion of endogenous aldose reductase 
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GRE3 increased xylonate yields from xylose and decreased accumulation of the unwanted side 
product xylitol, however total xylonate titer was decreased.  As xylose dehydrogenase requires 
NADP+ as a cofactor, three NADPH-consuming enzymes were co-expressed to increase pools of 
available NADP+.  Despite successfully expressing either E. coli transhydrogenase gene udhA, 
the B. subtilis glyceraldehyde 3-phosphate dehydrogenase gene gapB or the S. cerevisiae 
glutamate dehydrogenase gene GDH2, xylonate production was not further improved, suggesting 
that NADP+ was not the primary limitation of the constructed strains (Toivari et al., 2010).  A 
later report showed that xylose dehydrogenase xylB from C. crescentus showed superior function 
when expressed in yeast, doubling yields to 0.8 g xylonate / g xylose with a 3-4 fold increase in 
xylose consumption rate (Toivari et al., 2012).  In this instance, deletion of the GRE3 gene 
decreased accumulation of unwanted xylitol without significant impacts on xylonate production 
rates.  Xylose dehydrogenases produce xylonolactone from xylose, which then spontaneously or 
enzymatically is converted to xylonate.  Thus, expression of C. crescentus xylonolactone 
lactonase xylC was performed to further improve xylonate activity.  However, xylonate 
production rate and yields were not significantly improved.   The authors finally employed the 
Cre recombinase to replace two copies of the GRE3 gene with xylB in the industrial yeast strain 
B67002.  Although yields were maintained at 0.8 g xylonate / g xylose, volumetric xylonate 
productivity in the industrial strain (0.44 g/L/h) was roughly doubled as compared to xylB-
expressing laboratory yeast (0.20 g/L/h).  These efforts led to a maximum production of 43 g/L 
xylonate (Toivari et al., 2012). More recently, it was shown that xylonate production rapidly 
leads to a loss of cell viability, possibly due to rapid drop in intracellular pH (Nygård et al., 
2014) and activation of the PKA pathway causing an inability to adjust to stationary phase 
(Mojzita et al., 2014). Subsequently, co-production of xylitol and xylonate was investigated 
(Wiebe et al., 2015).  The C. crescentus aaor gene was identified and characterized, which 
encoded for an enzyme which converted xylose to xylitol in vitro without an added cofactor.  
After in vivo expression in yeast showed equimolar co-production of xylitol and xylonate from 
xylose, the aaor gene was suggested to encode for an aldose-aldose oxidoreductase which can 
both oxidize and reduce its substrate without interfering with cellular cofactor balance.  Co-
expression of C. crescentus aaor and xylC led to co-production of 11.5 g/L xylitol and 12.5 g/L 




2.4.10  Isoprenoids 
In another example of synergism between xylose consumption and production of non-
ethanol target molecules, production of isoprenoid compounds has been shown to be enhanced 
by coupling with xylose metabolism (Kwak et al., 2017). Yeast cells consuming xylose were 
found to more highly express the genes involved in ethanol assimilation and acetyl-CoA 
synthesis when cultured on xylose as opposed to glucose.  Additionally, overexpression of a 
HMG-CoA reductase with a truncated regulatory domain (tHMG1) was found to have higher 
activity normalized against total protein content of the cell when cultured on xylose rather than 
glucose.  To produce squalene from xylose, the oxidoreductive xylose consumption pathway was 
expressed followed by TAL1 overexpression to enhance consumption of xylose.  Next, the 
squalene production pathway (Figure 4) was enhanced by overexpression of ERG10 and tHMG1. 
Culturing on glucose or xylose led to specific squalene contents of 3.55 and 9.43 mg/g cell, 
respectively, and titers of 18.7 vs. 150 mg squalene/L, respectively, showing a near eight-fold 
increase in titer by using xylose as a carbon source.  From a fed-batch fermentation, 532 mg/L of 
squalene could be produced from xylose.  To produce amorphadiene from xylose, the 
amorphadiene production enzyme encoded by ADS was overexpressed in the strain described 
above followed by down-regulation of ERG9 to decrease flux towards squalene.  Following these 
genetic perturbations, amorphadiene was produced to 254 mg/L from xylose, roughly doubling 
the yield observed when the strain was cultured in glucose (Kwak et al., 2017). 
 
2.4.11  Spermidine 
Synthesis of spermidine, a polyamine with medical and agricultural applications 
(Nambeesan et al., 2010; Pichiah et al., 2011; Ramot et al., 2011; Rinaldi et al., 2004), may be 
repressed in the presence of glucose (S. K. Kim et al., 2017; White et al., 2001).  In a case like 
this, the use of xylose as a carbon source allows bypassing glucose repression and may enhance 
production of the target molecule.  In one report, the spermidine biosynthesis pathway (Figure 7) 
was repressed in the presence of glucose and use of xylose as a carbon source nearly doubled 
spermidine yield (S. K. Kim et al., 2017).  By overexpressing ornithine decarboxylase (SPE1), S-
adenosylmethionine decarboxylase (SPE2), spermidine synthase (SPE3), and a polyamine 
transporter (TPO1) coupled with deletion of the regulator ODC antizyme (OAZ1) to remove 
feedback inhibition on the biosynthesis pathway, the resulting strain produced 224 mg/L 
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spermidine from a mixture of glucose and xylose with a final yield of 2.2 mg spermidine / g 
sugars (S. K. Kim et al., 2017). 
 
2.5  Future prospects 
Many properties of xylose metabolism make it an attractive option in the production of 
compounds other than ethanol.  Unlike glucose metabolism which by the Crabtree effect is 
strongly optimized to direct flux towards ethanol production (Diaz-Ruiz et al., 2011), xylose 
metabolism instead elicits a respiratory response (Jin et al., 2004).  Consequently, central carbon 
metabolism from xylose consumption may be more amenable to perturbation and redirection 
towards desired pathways.  Particularly, reports reviewed here demonstrated that production of 
acetyl-CoA-derived molecules 1-hexadecanol, amorphadiene, and squalene were enhanced when 
coupled with xylose metabolism (Feng et al., 2015; Kwak et al., 2017).  It has been shown that 
yeast strictly regulates its growth based on glucose import and extracellular concentrations 
(Youk and Van Oudenaarden, 2009), which may suggest strong regulations upon acetyl-CoA 
availability in response to glucose.  While bypassing these strong glucose-based regulations may 
prove difficult when growing cells on glucose, xylose metabolism might not trigger these 
regulations at all.  Furthermore, a reduction in central carbon flux has been shown to enhance 
yields of some products (Dueber et al., 2009; Tan et al., 2016).  Current generation of xylose-
consuming engineered yeast consume xylose at lower rates than glucose and may reap these 
advantages without additional engineering. 
Of particular note, one result reviewed here demonstrated enhanced yield of lactic acid 
when employing xylose or xylose/cellobiose as carbon sources as opposed to glucose (Turner et 
al., 2016, 2015).  Although the mechanism behind this benefit has not yet been identified, it is 
noteworthy that pyruvate flux could be so easily redirected away from ethanol production when 
combined with xylose and cellobiose metabolism.  It is possible that this may be linked to 
mechanisms underlying the Crabtree effect, where glucose flux is rigidly directed towards 
ethanol (Diaz-Ruiz et al., 2011).  Alternatively, the benefit of xylose metabolism for lactic acid 
production may be linked to expression and stability of the carboxylic acid transporters Jen1 and 
Ady2, which have been shown to modulate production of lactic acid in engineered yeast 
(Pacheco et al., 2012).  It has been shown that at least Jen1 undergoes endocytosis and vacuolar 
degradation in response to glucose (Paiva et al., 2009), a mechanism which may not be triggered 
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during xylose metabolism.  The use of xylose as a carbon source again provided an avenue to 
bypass a stringent cellular regulation without extensive engineering of regulatory pathways.  It is 
likely that production of other value-added biomolecules which require expression of a 
transporter could be enhanced by xylose metabolism solely because of increased secretion 
capabilities. 
The unique advantages of xylose metabolism reviewed here coupled with recent 
advancements in simultaneous consumption of mixed sugars open the possibilities for new 
directions in metabolic engineering of yeast.  For example, dynamic pathway regulation is a 
metabolic engineering methodology that allows balancing of fluxes towards cell growth and 
production of chemicals (Tan and Prather, 2017).  Through either external inducers (Tan et al., 
2016) or autonomous regulation with engineered biosensors and gene circuits (Gupta et al., 
2017; Yuan and Ching, 2015), pathway flux is redirected from cell growth towards product 
formation based on stage of growth, cellular density, or at a critical concentration of an 
intracellular metabolite.  The advances reviewed here could expand these concepts to allow for 
flux partitioning strategies where one carbon source is exclusively used for cellular growth, 
maintenance, and metabolism while flux from the second carbon source is directed towards the 
target product.  Using glucose to sustain cell growth while xylose flux is directed towards a 
target product is an attractive option as it may be possible to essentially partition glycolysis and 
the pentose phosphate pathway in yeast through deletion of the transaldolase gene TAL1, which 
is not lethal (Giaever et al., 2002).  Moreover, recent characterization of sedoheptulose-7-
phosphate cyclases and identification of new downstream target products (Osborn et al., 2017) 
has revealed exciting new possibilities for value-added products dependent upon high flux 
through the pentose phosphate pathway. 
Although we have focused on the benefits of using lignocellulosic sugars to produce non-
ethanol compounds, many of the compounds reviewed here were simultaneously produced with 
ethanol.  While this may at first glance seem as if the engineered strains and production 
pathways require additional optimization, in many cases co-production of ethanol and high-value 
products may be beneficial for the economics of the industry.  While some high-value products 
may not have a sufficient market to justify being a primary product for a business, co-production 
of ethanol could provide additional revenue and serve as a financial buffer against occasions 
when the primary product has reached market saturation.  Similarly, co-production of a high 
26 
 
value compound along with ethanol may provide robust protection against fluctuating market 
prices of both feedstocks and ethanol.  In sum, co-production of high-value products and ethanol 
has potential to not only improve the economics of the bioethanol industry, but also expand the 
possibilities for viable businesses producing high-value compounds with relatively small 
markets. 
 
2.6  Conclusions 
Decades of research into lignocellulosic biofuels have generated vast knowledge on 
engineering S. cerevisiae to consume lignocellulosic sugars.  Although most studies have 
produced ethanol, recent developments have highlighted exceptional potential in employing 
engineered yeast for the bioconversion of lignocellulosic sugars to a variety of non-ethanol target 
products.  Additionally, a growing number of technologies developed to enable simultaneous 
assimilation of lignocellulosic sugars opens the door for new techniques in metabolic 
engineering of yeast for value-added biotransformation.  We expect future studies to find 
synergistic benefits of combining lignocellulosic sugar consumption with recent advances in 




2.7  Figures 
 
Figure 1 – Composition of lignocellulosic feedstocks.  





Figure 2 – Lignocellulosic sugar utilization pathways. 
(A) Pentose utilization pathways.  XI, xylose isomerase; XR, xylose reductase; XDH, xylitol dehydrogenase; XK, xylulokinase; AI, L-
arabinose isomerase; RK, L-ribulose kinase; RE, L-ribulose-5-phosphate epimerase; AR, L-arabinose reductase; ADH, L-arabitol 
dehydrogenase; LXR, L-xylulose reductase. (B) Cellodextrin utilization pathways.  Cellulases, either supplemented or secreted by 
engineered yeast, break down cellulose into cellodextrins which are then further metabolized by either secretion of enzymes, surface 
display of cellulases and β-glucosidases (BGL), or import into the cell with a cellodextrin transporter.  Imported cellodextrins are 
digested by either a BGL, producing two glucose molecules, a cellodextrin phosphorylase, producing one glucose-1-phosphate and a 
smaller cellodextrin, or a cellobiose phosphorylase (CBP), producing one glucose and one glucose-1-phosphate.  Phosphoglucomutase 




Figure 3 – Metabolic pathways involved in the production of xylitol, xylonate, lactic acid, 
2,3-butanediol, and isobutanol. 
XylR, xylose reductase; XylB, xylose dehydrogenase; XylC, xylonolactonase; LdhA, lactate 
dehydrogenase; Ilv2, acetolactate synthase; Aldc, acetolactate decarboxylase; Bdh, 2,3-
butanediol dehydrogenase; Ilv5, acetohydroxyacid reductoisomerase; Ilv3, dihydroxyacid 




Figure 4 – Metabolic pathways involved in the production of 1-hexadecanol, squalene, and 
amorphadiene.  
Reactions: Pdc, pyruvate decarboxylase; Ald6, aldehyde dehydrogenase; Acs, acetyl-CoA 
synthase; Acc, acetyl-CoA carboxylase; Far, fatty acyl-CoA reductase; Erg10, acetoacetyl-CoA 
thiolase; Erg13, HMG-CoA synthase; Hmg1, HMG-CoA reductase; Erg12, mevalonate kinase; 
Erg8, phosphomevalonate kinase; Mvd1, mevalonate pyrophosphate decarboxylase; Idi1, IPP-
DMAPP isomerase; Erg20; farnesyl pyrophosphate synthetase; Ads, amorphadiene synthase; 
Erg9, squalene synthase.  Intermediates: HMG, 3-hydroxy-3-methylglutaryl-CoA; IPP, 





Figure 5 – Metabolic pathways for producing 3-hydroxypropionic acid and poly-3-D-
hydroxybutyrate.  
Pyc, pyruvate carboxylase; Aat, aspartate transaminase; Pand, aspartate decarboxylase; Bapat, β-
alanine—pyruvate transaminase; Hpdh, 3-hydroxypropionate dehydrogenase; Badh, 3-
hydroxyisobutyrate dehydrogenase; Pdc, pyruvate decarboxylase; Ald6, aldehyde 
dehydrogenase; Acs, acetyl-CoA synthase; PhaA, acetoacetyl-CoA thiolase; PhaB1, acetoacetyl-
CoA reductase; PhaC1, polyhydroxybutyrate synthase; Acc, acetyl-CoA carboxylase; Mcr, 





Figure 6 – Metabolic pathways involved in the production of glycolic acid and co-
production of lactic acid with glycolic acid. 
Pyc, pyruvate carboxylase; Cit2, citrate synthase; Aco1, aconitase; Idp2, isocitrate 
dehydrogenase; Icl1, isocitrate lyase; Mls1, malate synthase; Mdh2, malate dehydrogenase; 
GlyR1, glyoxylate reductase; XylB, xylose dehydrogenase; XylC, xylonolactonase; XylD, 
xylonate dehydratase; YjhH and YagE, 2-keto-3-deoxyxylonate aldolase; AldA, aldehyde 






Figure 7 – Metabolic pathways involved in the production of spermidine. 
Car1, arginase; Arg3, ornithine carbamoyltransferase; Arg1, arginosuccinate synthetase; Arg4, 
argininosuccinate lyase; Spe1, ornithine decarboxylase; Spe2, S-adenosylmethionine 
decarboxylase; Spe3, spermidine synthase. 
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Table 1 – Typical composition of select lignocellulosic feedstocks as weight percentage on dry basis. 
 
Feedstock % Cellulose % Hemicellulose % Lignin Reference 
Miscanthus x giganteus 50.34 24.83 12.02 (Brosse, Dufour, Meng, Sun, & 
Ragauskas, 2012) 
Sugarcane bagasse 41.6 25.1 20.3 (M. Kim & Day, 2011) 
Energy cane 43.3 23.8 21.7 (M. Kim & Day, 2011) 
Switchgrass 33.48 26.1 17.35 (David & Ragauskas, 2010) 
Corn stover 37.0  31.3  17.8  (Saha, Yoshida, Cotta, & 
Sonomoto, 2013) 






Table 2 – Example sugar contents of lignocellulosic feedstocks as percentage of dry material. 
 
Feedstock % Arabinose  % Xylose  % Galactose  % Glucose  Reference 
Miscanthus x giganteus 2.78 21.68 0.35 50.47 (Le Ngoc Huyen, Rémond, Dheilly, & 
Chabbert, 2010) 
Sugar cane bagasse 1.68 22.07 11.14 44.3 (Sanjuan, Anzaldo, Vargas, Turrado, & Patt, 
2001) 
Switchgrass 3.8 23.1 1.2 38.8 (Hu, Sykes, Davis, Charles Brummer, & 
Ragauskas, 2010) 





Table 3 – Products, titers, and yields from bioconversion of lignocellulosic sugars by engineered S. cerevisiae. 
 
Product Carbon Sources Highest Yield Highest Titer Reference 
Xylitol Rice straw hydrolysate 0.79 g / g xylose 37.9 g/L (Guirimand et al., 2016) 




21 g/L (A. Kogje & Ghosalkar, 2016) 
Xylitol Glucose and xylan 0.71 g / g xylan 1.94 g/L (Zhe Li, Qu, Li, & Zhou, 
2013) 
Xylitol Cellobiose and xylose 1 g / g xylose 19.24 g/L (Zha et al., 2013) 
Xylitol Cellobiose and xylose 1 g / g xylose 93 g/L (E. J. Oh et al., 2013) 
Xylitol Glucose and xylose 0.96 g / g xylose 57 g/L (E. J. Oh et al., 2013) 
Xylitol Glucose and xylose 1 g / g xylose 196.2 g/L (Jo, Oh, Lee, Park, & Seo, 
2015) 
Xylitol Glucose and xylose 1 g / g xylose 91.3 g/L (E. J. Oh, Bae, Kim, Park, & 
Seo, 2012) 
Xylitol Glycerol and xylose 1 g / g xylose 47 g/L (A. B. Kogje & Ghosalkar, 
2017) 
Xylitol Glucose and xylose 1 g / g xylose 21 g/L (Stephan Lane, Xu, et al., 
2018) 
Isobutanol Xylose 0.16 mg / g xylose 1.36 mg/L (Brat & Boles, 2013) 




Table 3 continued on page 37 
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Table 3 – Products, titers, and yields from bioconversion of lignocellulosic sugars by engineered S. cerevisiae (continued). 
 
Product Carbon Sources Highest Yield Highest Titer Reference 
2,3-butanediol Xylose 0.27 g / g xylose 20.7 g/L (S. J. Kim, Seo, Park, Jin, & 
Seo, 2014) 
2,3-butanediol Glucose and xylose 0.29 g / g sugar 43.6 g/L (S. J. Kim et al., 2014) 
2,3-butanediol Xylose 0.38 g / g xylose 69.2 g/L (S. J. Kim et al., 2017) 
2,3-butanediol Cellobiose 0.29 g / g sugar 5.29 g/L (Nan et al., 2014) 
2,3-butanediol Glucose and galactose 0.35 g / g sugar 99.1 g/L (Choi et al., 2016) 
2,3-butanediol Glucose and galactose 0.36 g / g sugar >100 g/L (Lian, Chao, & Zhao, 2014) 
Ethylene glycol Xylose Not reported 14 mg/L (Salusjärvi et al., 2017) 
L-Lactic acid Xylose 0.69 g / g xylose 49.1 g/L (Turner et al., 2015) 
L-Lactic acid Cellobiose and xylose 0.73 g / g sugar 62 g/L (Turner et al., 2016) 
L-Lactic acid Glucose, cellobiose and xylose 0.66 g / g sugar 83 g/L (Turner et al., 2016) 
poly-3-D-hydroxybutyrate Xylose 1.99 mg / g xylose 101.7 mg/L (Sandström, Muñoz de las 
Heras, Portugal-Nunes, & 
Gorwa-Grauslund, 2015) 
poly-3-D-hydroxybutyrate Xylose 7.2 mg / g xylose 
(aerobic) 
7.0 mg / g xylose 
(anaerobic) 
252 mg/L (aerobic) 
360 mg/L (anaerobic) 
(de las Heras, Portugal-Nunes, 
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Table 3 – Products, titers, and yields from bioconversion of lignocellulosic sugars by engineered S. cerevisiae (continued). 
 
Product Carbon Sources Highest Yield Highest Titer Reference 
3-hydroxypropionate Xylose 0.17 g / g xylose 7.4 g/L (Kildegaard, Wang, Chen, 
Nielsen, & Borodina, 2015) 
Glycolic acid Xylose and ethanol Not reported 1 g/L (Koivistoinen et al., 2013) 
Glycolic acid Glucose and xylose Not reported 1.4 g/L (Salusjärvi et al., 2017) 
D-xylonate Glucose, xylose, and ethanol 0.4 g / g xylose 3.8 g/L (M. H. Toivari, Ruohonen, 
Richard, Penttilä, & Wiebe, 
2010) 
D-xylonate Glucose, xylose, and ethanol 0.8 g / g xylose 43 g/L (M. Toivari et al., 2012) 
D-xylonate and xylitol Glucose and xylose 1 g / g xylose 12.5 g/L D-xylonate 
11.5 g/L xylitol 
(Wiebe et al., 2015) 
Squalene Xylose Not reported 532 mg/L (Kwak et al., 2017) 
Amorphadiene Xylose 6 mg / g xylose 254 mg/L (Kwak et al., 2017) 







CHAPTER 3: BIOCONVERSION OF XYLOSE INTO ISOBUTANOL BY 





Bioconversion of xylose—the second most abundant sugar in nature—into high-value 
fuels and chemicals by engineered Saccharomyces cerevisiae has been a long-term goal of the 
metabolic engineering community.  Although most efforts have heavily focused on the 
production of ethanol by engineered S. cerevisiae, yields and productivities of ethanol produced 
from xylose have remained inferior as compared to ethanol produced from glucose.  However, 
this narrow-sighted focus on ethanol has concealed the fact that many aspects of xylose 
metabolism favor the production of non-ethanol products.  Through reduced overall metabolic 
flux, a more respiratory nature of consumption, and evading glucose signaling pathways, the 
bioconversion of xylose can be more amenable to redirecting flux away from ethanol towards a 
desired target product.  In this report, we show that coupling xylose consumption with a 
mitochondrially-targeted isobutanol biosynthesis pathway leads to enhanced product yields and 
titers as compared to cultures utilizing glucose, or galactose as a carbon source. Through 
optimization of culture conditions, we achieve 2.56 g/L and 2.6 g/L of isobutanol in fed-batch 
flask and bioreactor fermentations, respectively. These results suggest that there may be 
synergistic benefits of coupling xylose assimilation with the production of non-ethanol value-
added products.  
                                                 
2 The contents of this chapter have been submitted to a peer-reviewed journal.  I will be the lead 
author followed by Dr. Yanfei Zhang of Princeton University, Dr. Eun Ju Yun of Korea 
University, Professor Jose Avalos of Princeton University, and Professor Yong-Su Jin. 
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3.1  Introduction 
Over the past few decades, significant research has focused on the production of biofuels 
from renewable biomass (Bilal, Iqbal, Hu, Wang, & Zhang, 2018).  Current commercial biofuel 
production focuses mainly on the bioconversion of hexose sugars, such as those in corn starch 
and sugarcane, into ethanol (Bordonal et al., 2018; Marques, Moreno, Ballesteros, & Gírio, 
2017).  However, these feedstocks also participate in the food supply and therefore ignite the 
food versus fuel debate: heavy utilization of human-edible biomass may potentially increase food 
prices and exacerbate food insecurity (Filip, Janda, Kristoufek, & Zilbermam, 2017).  To bypass 
this debate, bioconversion of lignocellulosic biomass has been proposed.  In contrast to the 
human-edible sugars used as feedstocks in first-generation bioethanol, lignocellulosic biomass 
does not participate in the food supply and is comprised of cellulose, hemicellulose, and lignin, 
which can be depolymerized into a mixture of hexose and pentose sugars (Stephan Lane, Dong, 
& Jin, 2018).  In addition to avoiding the food versus fuel debate, lignocellulosic feedstocks are 
desirable due to their presence as agricultural wastes, overall high abundance, and relatively low 
cost (Ho, Ngo, & Guo, 2014). 
 Among microbes suitable for use in lignocellulosic bioconversion processes, the yeast 
Saccharomyces cerevisiae has been highly preferred due to its exceptional ethanol tolerance, 
relatively high resistance to fermentation inhibitors, and ease of engineering (Kwak & Jin, 2017).  
However, S. cerevisiae cannot natively assimilate xylose and thus significant efforts have been 
put towards engineering xylose-consuming yeast strains (S. R. Kim, Park, Jin, & Seo, 2013).  
Primarily, two xylose metabolism pathways have been employed: the isomerase pathway 
consisting of xylose isomerase (XI) and xylulose kinase (XK), and the oxidoreductive pathway 
consisting of xylose reductase (XR), xylitol dehydrogenase (XDH), and XK. 
In most cases, research involving engineered xylose-consuming yeasts has focused on the 
production of ethanol. However, accumulating evidence shows that utilizing xylose as a carbon 
source may allow enhanced production of a variety of non-ethanol products (S. Lane, Dong, & 
Jin, 2018).  Because xylose does not elicit the Crabtree effect in S. cerevisiae, metabolic fluxes 
during xylose fermentation by engineered S. cerevisiae are not rigidly directed towards ethanol, 




In this study, we aimed to produce the advanced biofuel isobutanol from xylose using 
engineered yeast.  The isobutanol biosynthesis pathway employed in this study consists of the 
endogenous acetolactate synthase (ILV2), ketol-acid reductoisomerase (ILV5) and dihydroxyacid 
dehydratase (ILV3) coupled with the Lactococcus lactis alpha-ketoisovalerate decarboxylase 
(Kivd), and alchohol dehydrogenase (AdhARE1) which has been engineered for increased affinity 
to isobutyraldehyde (Figure 8).  These biosynthetic enzymes are targeted into the mitochondria 
when expressed in yeast, which has been reported to increase production of isobutanol (Avalos, 
Fink, & Stephanopoulos, 2013).  Although this initial report of compartmentalizing the 
isobutanol pathway in the mitochondria for enhanced isobutanol production used glucose as a 
carbon source, glucose is known to lead to reduced mitochondrial genesis (Egner, Jakobs, & 
Hell, 2002).  We therefore aimed to investigate the effects of other carbon sources—specifically 
glucose, galactose, and xylose—on the production of isobutanol in an engineered yeast 
containing a mitochondrial-compartmentalized isobutanol production pathway. 
 
3.2  Materials and Methods 
3.2.1 Strains and plasmids 
 The xylose-consuming SR8 strain (S. R. Kim, Skerker, et al., 2013), which expresses the 
oxidoreductive xylose assimilation pathway (XYL1, XYL2, and XYL3) and contains a mutation in 
the PHO13 gene and a deletion of ALD6, was used in this study.  The auxotrophic SR8 ura- 
strain was created as described previously (Zhang et al., 2014) by deleting the URA3 gene using 
CRISPR genome editing. The mitochondrial-localized isobutanol pathway was expressed by 
transformation with the plasmid pJA180 (Avalos et al., 2013), and plasmid pRS426 
(Christianson, Sikorski, Dante, Shero, & Hieter, 1992) was used as an empty vector control. 
 
3.2.2 Media and culture conditions 
This study employed a nutrient-rich Verduyn (NRV) medium described previously with 
some modifications (Van Hoek, De Hulster, Van Dijken, & Pronk, 2000), which contained 15 
g/L (NH4)2SO4, 8 g/L KH2PO4, 3 g/L MgSO4, with 10 mL/L trace element solution and 12 mL/L 
vitamin solution.  The trace element solution was autoclaved for sterilization and contained 15 
g/L EDTA, 5.75 g/L ZnSO4, 0.32 g/L MnCl2, 0.5 g/L CuSO4, 0.47 g/L CoCl2, 0.48 g/L 
Na2MoO4, 2.9 g/L CaCl2, and 2.8 g/L FeSO4.  The vitamin solution was filter sterilized and 
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contained 0.05 g/L biotin, 1 g/L calcium pantothenate, 1 g/L nicotinic acid, 25 g/L myo-inositol, 
1 g/L thiamine hydrochloride, 1 g/L pyridoxol hydrochloride, and 0.2 g/L p-aminobenzoic acid.  
20 g/L CaCO3 was supplemented to flasks to maintain pH near 6.  Feed solution for fed-batch 
experiments contained 9 g/L KH2PO4, 2.5 g/L MgSO4, 3.5 g/L K2SO4, 0.28 g/L Na2SO4, 400 g/L 
xylose, 10 mL/L trace element solution and 12 mL/L vitamin solution. 
 Preculture was performed for 24 hours in culture tubes with 4 mL NRV medium with 20 
g/L glucose.  Flask fermentations were performed with 25 mL NRV media in 125 mL flasks at 
30°C.  Unless otherwise specified, flasks were agitated at 100 rotation per minute (RPM) and 
initial cell concentrations were set to an OD600 of 0.03. 
 The bioreactor experiment was initiated with a cell density equal to an OD600 of 0.03 in 
an initial volume of 1L NRV medium and 20 g/L xylose.  After consumption of the initial 
xylose, a single pulse feeding was used to increase xylose to 80 g/L.  Agitation was set to 200 
RPM, air flow was set to 0.5 liters per minute, and pH was maintained at 5.8 using 5M NaOH. 
 
3.2.3 Analytical methods 
Biomass was quantified as the absorbance at 600nm (OD600) using a Biomate 5 UV-
visible spectrophotometer (Fisher, NY, USA).  The concentration of sugars, glycerol, xylitol, and 
ethanol was measured using high-performance liquid chromatography (HPLC) (Agilent, Santa 
Clara, CA, USA) with a Rezex ROA-Organic Acid H+ (8%) column (Phenomenex Inc.) while 
the concentration of isobutanol was determined using gas chromatography (GC) (Agilent 
Technologies 7890A) with a flame ionization detector (FID) equipped with an HP-INNOWax 
column. The GC oven temperature was initially held at 30°C for 3 min and was then increased at 
a rate of 35°C/min to 225°C then held for 2 min. The injector temperature was held at 225°C, 
and the FID detector was held at 330°C. An injection volume of 1 μl and a split ratio of 2:1 was 
used for the analysis. Helium was used as a carrier gas.  Flux balance analysis was performed in 
Python (Python Software Foundation, 2013) using the COBRApy package (Ebrahim, Lerman, 
Palsson, & Hyduke, 2013) and the iMM904 yeast metabolic model (Mo, Palsson, & Herrgård, 





3.2.4 Metabolite profiling 
Metabolites were extracted using the fast filtration method (S. Kim et al., 2013) and 
profiled as described previously (Yun et al., 2018).  Biological duplicates were used along with 
technical triplicates for a total of six analyzed samples per culture condition.  SR8-Iso was grown 
to mid-exponential phase in NRV medium with glucose or xylose as a carbon source.  1 mL of 
culture was then filtered through a 0.45 µm nylon membrane filter (Whatman, Piscataway, NJ) 
followed by washing with 2 mL of distilled water.  The filter and filtered cells were then together 
submerged into a microfuge tube containing 200 µL of acid-washed 425-600 μm glass beads and 
1 mL of a cold 1:1 volume mixture of acetonitrile and water.  Metabolites were then extracted by 
vortexing for 3 minutes followed by pelleting of cell debris by centrifuging at 15,000 RPM at 
4°C for 5 minutes.  The supernatant was then collected and dried in a speed vacuum drier. 
Derivatization of metabolites was performed by methoxyamination and silylation.  First, 
5 μL of 40 mg/mL methoxyamine hydrochloride in pyridine (Sigma-Aldrich, St. Louis, MO) was 
added to the dried metabolites followed by incubation for 90 minutes at 30°C.  Next, 45 μL of N-
methyl-N-trimethylsilyltrifluoroacetamide (Sigma-Aldrich, St. Louis, MO) was added followed 
by incubation for 30 min at 37 °C. 
Derivatized samples were next analyzed through gas chromatography—mass 
spectrometry (GC-MS) following the protocol described previously (Yun et al., 2018). Briefly, 
the derivatized samples were analyzed in an Agilent 7890A GC/5975C MSD system (Agilent 
Technologies) equipped with an RTX-5Sil MS capillary column (30 m × 0.25 mm, 0.25 µm film 
thickness; Restek, Bellefonte, PA) and an integrated guard column. A 1 µL sample was injected 
into the GC inlet in splitless mode. The oven temperature was set to the following: 150 °C for 1 
min, then increased to 330 °C at 20 °C/min, and held at 330 °C for 5 minutes. The mass spectra 
were recorded in a scan range 85–500 m/z at electron impact of 70 eV.  The temperature of the 
ion source was 230 °C while the transfer line was 280 °C. 
The raw data obtained from GC/MS analysis were pre-processed in automated mass 
spectral deconvolution and identification system (AMDIS) software (Stein, 1999) for peak 
detection and deconvolution of mass spectra, which was then analyzed by SpectConnect 
(http://spectconnect.mit.edu) (Styczynski et al., 2007) for peak alignment and generation of the 
data matrix using the Golm Metabolome Database (GMD) mass spectral reference library 
(Kopka et al., 2005). The normalized abundance values for each metabolite were calculated by 
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dividing peak intensity by the dry cell weight. Statistica (version 7.1; StatSoft, Palo Alto, CA) 
and MultiExperiment Viewer software (Ochs, Casagrande, & Davuluri, 2010) were used for 
statistical analysis and generation of heat maps, respectively. 
 
3.3  Results 
Strain SR8-Iso was created by transforming SR8 ura- with plasmid pJA180, consisting of 
the mitochondrial-targeted isobutanol pathway S. cerevisiae ILV2, ILV3, and ILV5 with 
Lactococcus lactis Kivd and engineered AdhARE1 (Figure 8) (Avalos et al., 2013).  As a control, 
empty vector pRS426 was also transformed into SR8 ura- yielding SR8-C.  These strains were 
then cultured with either glucose (Figure 9), galactose (Figure 10), or xylose (Figure 11) as a sole 
carbon source.  The SR8-Iso strain fermented each sugar more slowly and, apart from the 
glucose culture, yielded less ethanol than the control strain SR8-C.  As expected, the SR8-Iso 
strain consistently produced more isobutanol than the empty vector control strain SR8-C.   
 The SR8-Iso strain grew, consumed sugar, and produced ethanol more slowly on xylose 
than any other carbon source (Figure 12A).  However, culturing the SR8-Iso strain on xylose 
yielded nearly six-fold more isobutanol (24.6 mg isobutanol/g xylose) than any other carbon 
source (4.2 mg isobutanol/g glucose and 4.3 mg isobutanol/g galactose) (Figure 12B).  Starting 
with about 40 g/L of sugar, 872 mg/L of isobutanol was produced from xylose while 156 mg/L 
and 168 mg/L of isobutanol were produced from glucose and galactose, respectively.  In 
contrast, the SR8-Iso strain produced the most ethanol from glucose (12.8 g/L ethanol at a yield 
of 0.34 g ethanol/g sugar) followed by galactose (11.2 g/L ethanol at a yield of 0.28 g ethanol/g 
sugar), while the least amount of ethanol was produced from xylose (6.2 g/L ethanol at a yield of 
0.18 g ethanol/g sugar). 
 We next aimed to optimize the production of isobutanol from xylose by varying the 
fermentation parameters of initial sugar concentration, agitation, and initial cell inoculum.  
Although the initial xylose concentration largely impacted the production of ethanol, there were 
no large changes in the yield of isobutanol (Figure 13A).  However, culturing with lower initial 
xylose (20 g/L) led to faster cell growth, sugar consumption, and isobutanol production than 
higher amounts of xylose (40 or 80 g/L) (Figure 14).  In contrast, the rate of agitation 
substantially impacted the production of both ethanol and isobutanol (Figure 13B and Figure 15).  
While the yield of ethanol increased as agitation was reduced, the isobutanol was most optimally 
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produced from xylose with flask agitation at 100 RPM.  Similarly, initial cell inoculum had a 
large impact on the production of isobutanol (Figure 13C and Figure 16).  By culturing with an 
initial cell inoculum equal to an OD600 of 0.003, isobutanol was yielded from xylose at 36.1 ± 1.2 
mg isobutanol/g xylose as compared to 27.1 ± 1.1 mg isobutanol/g xylose and 23.7 ± 0.4 mg 
isobutanol/g xylose for initial cell inoculums of OD600 equal to 0.03 and 1, respectively.  
However, lower inoculums led to a significantly longer fermentation period; 160 hours was 
required to consume 40 g/L of xylose when initial OD600 = 0.003 as compared to 66 hours for 
initial OD600 = 1. 
 Using this information, we performed a fed-batch fermentation aiming to produce a high 
titer of isobutanol.  We began with 20 g/L xylose to maximize production rates and, to strike a 
balance between high yields and a reasonable fermentation length, inoculated the fermentation 
with an initial OD600 equal to 0.1.  After consumption of the available sugar, additional xylose 
was fed to replenish the medium to near 20 g/L xylose.  The initial phase of the fermentation 
showed strong production of isobutanol; around 1g/L isobutanol was produced from the first 40 
g/L of consumed xylose (Figure 17).  However, production began to taper off in the later stages 
of the fermentation as xylose was consumed slower.  In total, 2.56 g/L isobutanol was produced 
from roughly 190 g/L consumed xylose. 
 Because all fermentations thus far were performed in flasks with 25 mL medium, we next 
performed a 1L bioreactor fermentation to investigate the potential for scaling up.  Although we 
attempted to emulate our strategy during flask fed-batch fermentations of starting with 20 g/L 
xylose followed by repeated feeding to 20g/L xylose, this method did not lead to substantial 
production of isobutanol (data not shown).  Instead, starting with 20 g/L of xylose, allowing 
consumption to <5 g/L of xylose, then feeding to 80 g/L of xylose led to production of 2.6 g/L of 
isobutanol (Figure 18). 
 In order to gain some insight into why xylose assimilation leads to a nearly six-fold 
improvement in production of isobutanol as compared to glucose fermentation, we next 
performed metabolite profiling to obtain a systems-level analysis of the strains cultured in 
different carbon sources (Figure 19). We thus cultured the SR8-Iso strain in NRV medium with 
either glucose or xylose as carbon sources and sampled for metabolite analysis in mid-
exponential phase.  Metabolites were extracted, derivatized, and profiled as described in the 
materials and methods.  There were clear differences in the quantity of valine and isoleucine, key 
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metabolites related to the isobutanol production pathway.  While isoleucine contents were higher 
in glucose cultures, xylose cultures led to increased accumulation of valine. 
 
3.4  Discussion 
Although there has been a prior report of production of isobutanol from xylose using 
engineered S. cerevisiae, the quantity was quite low at 1.36 ± 0.11 mg isobutanol/L from the 
consumption of 12 g/L of xylose (Brat & Boles, 2013).  The consumption of xylose was slow 
compared to the strains presented in this study, which may have had a large effect on production 
capabilities.  Additionally, the production pathway was not localized to the mitochondria, which 
may not take full advantage of the respiratory nature of xylose metabolism in engineered yeast 
(Jin, Laplaza, & Jeffries, 2004).  Although that original report was a great proof-of-concept for 
bioconversion of xylose to isobutanol, our over 300-fold improvement in production yield shows 
that utilization of xylose to produce isobutanol is a problem worth revisiting. 
The work presented here mirrors several recent studies finding improved yields from 
established production pathways solely by using xylose as a carbon source.  Expression of the 
Rhizopus oryzae lactic acid dehydrogenase ldhA led to a yield of 0.69 g lactic acid/g xylose, as 
opposed to a yield of 0.22 g lactic acid/g glucose (Turner et al., 2015).  It has also been shown 
that production of squalene and amorphadiene is enhanced by consumption of xylose instead of 
glucose (Kwak et al., 2017).  While glucose induces the Crabtree effect in S. cerevisiae (Diaz-
Ruiz, Rigoulet, & Devin, 2011), consumption of xylose exhibits a respiratory response (Jin et al., 
2004).  This may lead to a metabolic state more easily modified for redirection of flux towards 
desired products. This may help explain the enhanced production of isobutanol presented here as 
well as lactic acid and isoprenoids published elsewhere. 
Interestingly, flux balance analysis does not predict any advantage of utilizing xylose 
over glucose when producing isobutanol (Figure 20).  This indicates that enhanced isobutanol 
production during xylose assimilation is the result of changes in cellular physiology or regulatory 
mechanisms.  It is possible that different metabolic regulation leads to differing accumulation of 
intracellular metabolites, which could not be predicted by steady-state modeling as in flux 
balance analysis.  Indeed, the metabolite profiling results may suggest a mechanism for enhanced 
isobutanol production when using xylose as the major carbon source.  In xylose cultures, valine 
contents were increased while isoleucine was decreased.  This may suggest that pyruvate flux 
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was more directed towards α-ketoisovalerate, an intermediate in isobutanol and valine 
biosynthesis, than α-keto-3-methylvalerate, an intermediate in isoleucine biosynthesis.  Although 
we were unable to clearly detect pyruvate during our metabolite profiling, these results could be 
explained by higher steady-state pyruvate concentrations.  As two pyruvate are required to 
produce one molecule of α-ketoisovalerate, a higher steady-state pyruvate concentration would 
favor this reaction and direct additional flux towards isobutanol.  An increased steady-state 
pyruvate concentration during xylose metabolism, increasing production of non-ethanol 
molecules biosynthesized from pyruvate, may also help explain why xylose enhances the 
production of lactic acid, squalene, and amorphiadene as described above. 
Additionally, the slower consumption of xylose as compared to glucose might be 
inherently beneficial for producing isobutanol.  Recently, it has been shown that implementing a 
flux valve increases the yield of isobutanol from engineered S. cerevisiae (Tan, Manchester, & 
Prather, 2016).  Endogenous hexokinases GLK1 and HXK2 were deleted alongside down-
regulation of HXK1 using a doxycycline-inducible repressor, leading to a reduced rate of glucose 
phosphorylation and lowered glycolytic flux.  Addition of the isobutanol production vector used 
in this study, pJA180, led to a nearly 3-fold improvement in production yields.  In a future study, 
it may be interesting to see how the xylose consumption rate influences the yield of isobutanol 
by using a set of strains with varied xylose consumption capabilities.  Such a set of strains has 
been created in the past by varying the expression level of transaldolase TAL1 (Xu et al., 2016), a 
key player in the pentose phosphate pathway and a major determinant of the overall xylose 
consumption rate.  
Although the price of xylose is currently high while availability remains low, full 
incorporation of lignocellulosic biomass into the biorenewable economy will make xylose an 
inexpensive and abundant sugar. As reported in this and prior reports, xylose can be an effective 
sugar for the production of non-ethanol products due to the unique physiology and gene 





3.6  Figures 
 
Figure 8 – Metabolic pathways for bioconversion of xylose to isobutanol. 
Xylose reductase converts xylose to xylitol, which is then converted to xylulose by xylitol 
dehydrogenase.  Xylulose is then phosphorylated by xylulose kinase where it enters the pentose 
phosphate pathway and central carbon metabolism.  pJA180, the isobutanol production plasmid 
used in this study, overexpresses endogenous ILV2, ILV3, and ILV5 with mitochondrial-targeted 






Figure 9 – Isobutanol production from glucose. 
Empty-vector control strain SR8-C was compared to the isobutanol-producing SR8-Iso strain 
during the fermentation of glucose.  Fermentations were performed in 125 mL flasks containing 
25 mL medium and 20 g/L CaCO3 at 30°C and 100 rpm with an initial cell inoculum equal to an 
OD of 0.03 at 600 nm.  Data points are the average of two biological duplicates.  Error bars 






Figure 10 – Isobutanol production from galactose. 
Empty-vector control strain SR8-C was compared to the isobutanol-producing SR8-Iso strain 
during the fermentation of galactose.  Fermentations were performed in 125 mL flasks 
containing 25 mL medium and 20 g/L CaCO3 at 30°C and 100 rpm with an initial cell inoculum 
equal to an OD of 0.03 at 600 nm.  Data points are the average of two biological duplicates.  




   
 
Figure 11 – Isobutanol production from xylose. 
Empty-vector control strain SR8-C was compared to the isobutanol-producing SR8-Iso strain 
during the fermentation of xylose.  Fermentations were performed in 125 mL flasks containing 
25 mL medium and 20 g/L CaCO3 at 30°C and 100 rpm with an initial cell inoculum equal to an 
OD of 0.03 at 600 nm.  Data points are the average of two biological duplicates.  Error bars 






Figure 12 – Carbon source affects production of isobutanol. 
(A) Fermentation profiles of SR8-Iso cultured on glucose (blue squares), galactose (pink circles), 
or xylose (yellow triangles) displaying cell density (top left), sugar (top right), ethanol (bottom 
left), and isobutanol (bottom right) concentrations.  Fermentations were performed in 125 mL 
flasks containing 25 mL medium and 20 g/L CaCO3 at 30°C and 100 rpm with an initial cell 
inoculum equal to an OD of 0.03 at 600 nm.  Data points are the average of two biological 
duplicates.  Error bars indicate standard deviations and are not visible when smaller than the 
symbol size.  (B) Ethanol and isobutanol yields of the SR8-Iso and control SR8-C strains 
cultured on glucose, galactose, and xylose.  Displayed values are the average of two biological 





Figure 13 – Optimization of isobutanol production in strain SR8-Iso. 
The effects of (A) initial sugar concentration, (B) agitation, and (C) initial cell inoculum on 
ethanol (orange bars) and isobutanol (blue bars) yields.  Displayed values are the average of two 
biological duplicates with error bars indicating standard deviations.  Yields are calculated from 
fermentations performed in 125 mL flasks containing 25 mL medium and 20 g/L CaCO3 at 
30°C.  Figures 13A and 13B were performed with initial cell inoculum equal to an OD600 of 
0.03, figures 13A and 13C were performed at 100 RPM, and figures 13B and 13C were 
performed with an initial xylose concentration of 40 g/L.  Full fermentation profiles for 13A, 





Figure 14 – Effect of initial xylose concentration on the production of isobutanol. 
The isobutanol-producing SR8-Iso strain was cultured with various initial xylose concentrations.  
Fermentations were performed in 125 mL flasks containing 25 mL medium and 20 g/L CaCO3 at 
30°C and 100 rpm with an initial cell inoculum equal to an OD of 0.03 at 600 nm.  Data points 
are the average of two biological duplicates.  Error bars indicate standard deviations and are not 





Figure 15 – Effect of aeration on the production of isobutanol. 
The isobutanol-producing SR8-Iso strain was cultured with various levels of agitation to 
investigate the effects of aeration on isobutanol production.  Fermentations were performed in 
125 mL flasks containing 25 mL medium and 20 g/L CaCO3 at 30°C with an initial cell 
inoculum equal to an OD of 0.03 at 600 nm.  Data points are the average of two biological 
duplicates.  Error bars indicate standard deviations and are not visible when smaller than the 






Figure 16 – Effect of initial cell inoculum on the production of isobutanol. 
The isobutanol-producing SR8-Iso strain was cultured with varied initial cell concentrations.  
Fermentations were performed in 125 mL flasks containing 25 mL medium and 20 g/L CaCO3 at 
30°C and 100 rpm.  Data points are the average of two biological duplicates.  Error bars indicate 





Figure 17 – Fed-batch fermentation for isobutanol production. 
Fed-batch fermentation performed in 125 mL flask containing 25 mL medium and 20 g/L CaCO3 
at 30°C and 100 rpm with an initial cell inoculum equal to an OD600 of 0.1.  Data points are the 
average of two biological duplicates.  Error bars indicate standard deviations and are not visible 




Figure 18 – Isobutanol production in a one-liter bioreactor. 
One-liter bioreactor fermentation starting with 20 g/L initial xylose followed by a pulse to 80 g/L 
xylose.  The fermentation was inoculated with a cell density equal to an OD600 of 0.03 NRV 
medium.  Agitation was set to 200 RPM, gas flow was set to 0.5 liters per minute, and pH was 




Figure 19 – Carbon source affects the metabolite profile of the SR8-Iso strain. 
Metabolite profiles of the SR8-Iso strain cultured on either glucose or xylose.  Metabolites were 
extracted and quantified from cells grown in mid-exponential phase as described in the materials 





Figure 20 – Simulating isobutanol production through flux balance analysis. 
The genome-scale metabolic model iMM904 was employed with the COBRApy python package 
for simulation of metabolic fluxes.  Glucose metabolism was compared to the oxidoreductive 
xylose consumption pathway.  The simulated isobutanol production pathway was 
compartmentalized into the mitochondria.  The growth rate was analyzed in response to flux 




CHAPTER 4: MICROBIAL PRODUCTION OF THE RARE SUGAR 







Sedoheptulose is a seven-carbon sugar found in small quantities in some plants.  Some of 
these plants are commonly consumed by humans, such as carrots, and as such sedoheptulose is a 
small part of the human diet.  There are reports that this sugar may have anti-inflammatory and 
anti-diabetic properties, but its high price  has hindered research into the properties and health 
effects of this sugar.  As of the time of this writing, the lowest publicly-listed price for 
sedoheptulose was $344 for 10 mg of 95% pure sugar.  Because of this expense, those few 
researchers who have studied the health effects of this sugar have personally extracted it from 
plants such as Sedum spectabile.  In this chapter, a reliable and stable method of producing 
sedoheptulose is presented.  It has been reported previously that the yeast broad-spectrum 
phosphatase PHO13 has activity towards the pentose phosphate pathway intermediate 
sedoheptulose-7-phosphate (S7P) (Xu et al., 2016), allowing dephosphorylation into 
sedoheptulose.  By overexpression of this phosphatase in the xylose-consuming engineered yeast 
strain SR8 (S. R. Kim, Skerker, et al., 2013), high flux through the pentose phosphate pathway 
coupled with dephosphorylation of the pentose phosphate pathway intermediate S7P leads to 
production of sedoheptulose.  Optimization of fermentation conditions and preventing S7P from 
entering central carbon metabolism by deletion of the TAL1 gene leads to a maximal yield of 
roughly 0.4 g sedoheptulose / g xylose fed at titers of around 16 g/L sedoheptulose in a flask.  





4.1  Introduction 
 Interest has grown in the identification and production of rare sugars which retain 
sweetening capabilities while providing little to no calories after consumption.  For example, the 
six-carbon rare sugar tagatose is a low-calorie generally-recognized-as-safe (GRAS) sweetener 
(Levin, 2003) with minimal effects on blood sugar levels (Livesey & Brown, 2018).  These 
properties have even led the sugar to be described as an obesity control and antidiabetic drug 
(Lu, Levin, & Donner, 2008).  Additionally, as humans cannot substantially metabolize this 
sugar, it can be coupled with a probiotic as a carbon source for the microbe (Koh, Kim, & Park, 
2015). These properties have made this rare sugar industrially desired and, as such, a large 
number of tagatose production methods have been proposed (Bosshart, Wagner, Lei, Panke, & 
Bechtold, 2016; Cheetham & Wootton, 1993; Drabo & Delidovich, 2018; Jayamuthunagai, 
Gautam, Srisowmeya, & Chakravarthy, 2017; D. K. Oh, 2007; Sha et al., 2018; Yinjun Xu, 
2013).  Psicose, another six-carbon rare sugar, has similar low-calorie properties to tagatose 
(Matsuo, Suzuki, Hashiguchi, & Izumori, 2011). A number of reported health benefits (Bosshart 
et al., 2016; Chung, Oh, & Lee, 2012; A. Hossain et al., 2015, 2012; M. A. Hossain et al., 2011; 
Matsuo et al., 2011; Nagata, Kanasaki, Tamaru, & Tanaka, 2015), along with its sweet 
properties, have driven researchers and companies to research and develop production 
methodologies  (Bosshart et al., 2016; C. Li et al., 2018; Zijie Li et al., 2015; Mu, Zhang, Feng, 
Jiang, & Zhou, 2012; Park, Park, Shin, & Oh, 2016; Song, Nguyen, Wi, Yang, & Bae, 2017).  
With similar properties to bulk sweeteners minus the health detriments of natural sugars, such as 
over intake of calories and diabetic potential, rare sugars have emerged as an attractive option for 
developing low-calorie products with sweet tastes. 
 In comparison to psicose and tagatose, the rare seven-carbon sugar sedoheptulose has 
been studied far less extensively.  In contrast to the previous sugars, the price of sedoheptulose is 
prohibitive even for most researchers.  In fact, most publications studying the health effects of 
sedoheptulose have manually extracted the sugar from plants in order to obtain quantities usable 
for their studies (Haschemi et al., 2012; Haschemi, Wagner, Nagy, & Marculescu, 2014b; 
Ujejski & Waygood, 1955).  Microbial production of sedoheptulose was proposed after isolation 
of a mutant strain which accumulated the sugar naturally, however the strain was reported to be 
unstable, required feeding of arabinose to induce the accumulation of sedoheptulose, and no 
follow-up studies were performed (Yokota, 1993). 
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 Despite these setbacks, some potential benefits of sedoheptulose consumption have been 
identified.  Sedoheptulose has been demonstrated to control macrophage polarization (Haschemi 
et al., 2012), which indicates that it may have utility as an anti-inflammatory agent (Haschemi et 
al., 2014b).  Sedoheptulose as a nutritional supplement has also been proposed (Haschemi, 
Wagner, Nagy, & Marculescu, 2014a). 
 Here, a new method is developed for producing sedoheptulose is demonstrated using the 
yeast broad spectrum phosphatase PHO13 (Xu et al., 2016) in the engineered xylose-consuming 
yeast strain SR8 (S. R. Kim, Skerker, et al., 2013).   Further genetic modification of the pentose 
phosphate pathway is also used to direct maximal flux toward sedoheptulose and reduce the 
accumulation of byproducts. 
 
4.2  Methods 
4.2.1 Strains, media and culture conditions 
This study used the xylose-consuming SR8 strain (S. R. Kim, Skerker, et al., 2013), 
which expresses the oxidoreductive xylose assimilation pathway (XYL1, XYL2, and XYL3) and 
contains a mutation in the PHO13 gene and a deletion of ALD6.  The pRS42H-PHO13 plasmid 
was created by placing the PHO13 gene under control of the GPDp promoter on the pRS42H 
plasmid, which contains a hygromycin yeast selection marker and a 2-micron high copy number 
origin of replication.  
The genomic overexpression PHO13 strain was created by integrating the PHO13 
overexpression cassette into the PBN1/SBP1 intergenic region (Flagfeldt, Siewers, Huang, & 
Nielsen, 2009) using CRISPR genome editing.  CRISPR donor DNA was amplified from the 
pRS42H-PHO13 plasmid using primers M13_d_f and M13_d_r (Table 4).  Successful 
integration was confirmed using colony PCR with confirmation primers M13_c_f and M13_c_r. 
The deletion of the TAL1 gene was also performed by CRISPR genome editing.  A 20 base pair 
sequence containing a stop codon and frameshift was inserted into the beginning of the TAL1 
gene using a 120 base pair donor DNA created using primers ΔTAL1_d_f and ΔTAL1_d_r 
(Table 4).  The knockout was confirmed by using colony PCR to verify the insertion of the 
frameshift and stop codon by using a confirmation primer upstream of the insertion 
(ΔTAL1_c_f) and a reverse primer comprised of the 20 inserted base pairs (ΔTAL1_c_r).  
Overexpression of TKL1 was performed by amplifying two donors, the CCW12p promoter and 
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the TKL1 gene and terminator with homology overlaps in the CCW12 promoter, and integrating 
them into the CS6 integration site (Kwak et al., 2017) through homologous recombination during 
CRISPR genome editing.  To prevent mutations within the TKL1 gene occurring during 
homologous recombination of promoter and gene fragments, the assembly of the promoter and 
gene was performed with homology entirely within the promoter sequence.  The pCCW12 donor 
fragment containing 40 base pairs of homology with CS6 upstream of the CCW12 promoter was 
amplified from D452 genome DNA using primers CS6_pCCW12_f and pCCW12_r.  The TKL1 
donor fragment, containing 40 base pairs of homology with the CCW12 promoter at the 
beginning of the fragment and 40 base pairs of homology with the CS6 site after the TKL1 
terminator, was amplified using primers pCCW12_TKL1_f and CS6_tTKL1_r.  Correct 
assembly was first verified through colony PCR using a forward primer upstream of the CS6 
insertion site (CS6_c_f) and a reverse primer within the TKL1 gene (TKL1_c_r).  Following size 
verification through colony PCR, the entire pCCW12_TKL1_TKL1t expression cassette was 
amplified from genome DNA using primers pCCW12_TKL1_seq_f and pCCW12_TKL1_seq_r 
then sequenced using primers pCCW2-TKL1_seq_1, pCCW2-TKL1_seq_2, pCCW2-
TKL1_seq_3, and pCCW2-TKL1_seq_4.  The primers used for integrating the PHO13 
overexpression cassette, deleting TAL1, or creating and integrating the CCW12p-TKL1 
expression cassette are listed in Table 4.  The Cas9 target sites used in this study are listed in 
Table 5. 
All cultures were performed in YP (10 g/L yeast extract and 20 g/L Bacto peptone) 
medium.  Flask fermentations were performed in 25 mL media in 125 mL flasks.  The bioreactor 
fermentation was carried out at 1L scale.  For fermentations with the strain holding the pRS42H-
PHO13 plasmid, 200 µg/mL hygromycin was added to maintain the plasmid. 
 
4.2.2 Analytical methods 
Biomass was quantified as the absorbance at 600nm (OD600) using a Biomate 5 UV-
visible spectrophotometer (Fisher, NY, USA).  The concentration of glucose, xylose, 
sedoheptulose, glycerol, xylitol, and ethanol were measured using high-performance liquid 
chromatography (HPLC) (Agilent, Santa Clara, CA, USA) with a Rezex ROA-Organic Acid H+ 
(8%) column (Phenomenex Inc.).  A sedoheptulose standard (Sigma Aldrich) was used to 
confirm the presence of sedoheptulose in fermentations from this study. 
65 
 
4.3  Results and Discussion 
4.3.1 Production of sedoheptulose by overexpression of the PHO13 gene 
We introduced the pRS42H-PHO13 plasmid, containing an overexpression cassette of the 
PHO13 gene driven by the GPD promoter, into the SR8 strain, yielding strain SR8-42H-PHO13.  
As a control, we also transformed the SR8 strain with the pRS42H empty vector, yielding strain 
SR8-42H.  The PHO13 gene, which has previously found to have activity towards S7P (Xu et 
al., 2016), should then dephosphorylate S7P into sedoheptulose if there is sufficient flux through 
the pentose phosphate pathway (Figure 21). 
We then tested the strains in a fermentation containing YP medium along with 40 g/L 
each of glucose and xylose (Figure 22).  Both strains rapidly consumed glucose within 20 hours 
followed by consumption of xylose.  The empty vector control strain finished xylose 
consumption within 48 hours while strain SR8-42H-PHO13 consumed xylose slower, requiring 
around 72 hours for complete xylose consumption.  The PHO13-overexpressing strain also 
yielded less glycerol, ethanol, and biomass than the empty vector strain. Sedoheptulose 
accumulated to over 0.6 g/L in the fermentation with strain overexpressing PHO13 but was not 
detected at all in the supernatant from the empty vector control strain.  This confirmed the 
necessity of phosphatase overexpression in order to produce sedoheptulose from xylose. 
We next varied several fermentation parameters in order to optimize the production of 
sedoheptulose: agitation, carbon source, initial xylose concentrations, and initial cell inoculum 
(Figure 23).  High agitation and low initial cell inoculum were found to produce the highest 
yields of sedoheptulose (Figure 23A,D), indicating that aeration was important towards obtaining 
high sedoheptulose production. Additionally, an initial pulse of glucose benefited the production 
of sedoheptulose (Figure 23B), possibly by producing a population of healthy cells which then 
can allow quick bioconversion of xylose into sedoheptulose.  Finally, lower xylose 
concentrations were found to lead to the highest yields of sedoheptulose (Figure 23C).  Although 
the yields were higher, the overall production was reduced due to the lesser amount of input 
sugar available for bioconversion.  In order to balance high yields and high production titers, all 
future fermentations were carried out at 250 RPM, with an initial cell inoculum of 0.01, with 40 
g/L xylose and an initial glucose concentration of 40 g/L. 
Plasmid based overexpression of PHO13 has several limitations.  First of all, use of a 
plasmid can lead to noisy expression of a target gene (Ryan et al., 2014), creating a non-
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homogenous population of cells with some high-producing and low-producing components.  
Secondly, maintaining plasmid selection – in this case with the presence of an antibiotic – is 
necessary to preserve the presence of the plasmid within the population.  To bypass these issues, 
we next decided to create a strain with a PHO13-overexpression cassette integrated into the yeast 
genome  We thus amplified the PHO13-overexpression cassette and used the PCR product as a 
donor DNA in CRISPR genome editing targeted to the PBN1/SBP1 intergenic region (Flagfeldt 
et al., 2009), as described in the materials and methods.  The genome and plasmid-based 
PHO13-overexpression strains were next compared in a fermentation (Figure 24).  Genome 
integration of PHO13 led to faster and higher production of sedoheptulose and quicker 
completion of xylose consumption.  This effect is likely due to two factors: a homogenous 
population of near-equal sedoheptulose producers as well as the lack of an antibiotic to slow cell 
growth and sugar consumption. 
As shown in Figure 21, S7P can be dephosphorylated into sedoheptulose or can continue 
in the pentose phosphate pathway and enter central carbon metabolism.  To push flux towards 
sedoheptulose production and reduce the quantity of xylose used to cell growth and maintenance, 
we deleted the TAL1 gene in the SR8 strain with genome-based overexpression of PHO13 and 
compared the two strains in a fermentation (Figure 25).  Although deletion of TAL1 significantly 
slowed the bioconversion of xylose, the production of sedoheptulose was nearly quadrupled from 
4 g/L to nearly 16 g/L.  However, deletion of TAL1 also led to increased accumulation of the 
undesirable intermediates xylitol and xylulose. 
To reduce the accumulation of xylulose, we next tried to push flux towards S7P by 
overexpression of the TKL1 gene, which controls the conversion of xylulose-5-phosphate and 
ribose-5-phosphate into S7P and glyceraldehyde-3-phosphate.  However, this did not 
significantly reduce the production of xylulose (Figure 26). 
Commercializing the production of sedoheptulose would require significantly higher 
scales than those investigated thus far.   We therefore decided next to scale up production of 
sedoheptulose in a 1L bioreactor with controlled feeding of glucose (Figure 27).  In total, we 
were able to produce over 25 g/L of sedoheptulose using this bioreactor setup.  However, this 
also came with significant production of undesired byproducts.  Specifically, xylulose 
accumulated to roughly 20 g/L and xylitol and glycerol accumulated to nearly 7 and 80 g/L, 
respectively.  In general, the yield and overall efficiency of sedoheptulose production was 
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substantially reduced upon scaling up.  Moving forward, the fermentation parameters will need 
further optimization to allow high-yield production of sedoheptulose at large scale using 
engineered yeast.  It is possible that the high concentration of cells led to an oxygen-limited 
environment and increasing aeration may improve production.  Additionally, while glucose was 
fed repeatedly in these experiments, it may be optimal to feed ethanol or another consumable 
carbon source instead of glucose.  On the other hand, if glucose is found to be the best co-
substrate, the feeding rate and quantity could be optimized to enable high production of 
sedoheptulose.  Furthermore, although the overexpression of TKL1 was found to have little effect 
at low scales, it may be worth revisiting the perturbation of pentose phosphate pathway genes to 




4.4  Figures 
 
 
Figure 21 – Sedoheptulose production pathway. 
The XYL123 pathway in the SR8 strain allows metabolizing xylose in the pentose phosphate 






Figure 22 – Production of sedoheptulose by overexpression of PHO13 on the pRS42H 
plasmid. 
Strain SR8 with empty vector pRS42H or PHO13 overexpression vector pRS42H-PHO13 was 
cultured in 25 mL YP medium in 125 mL flasks with 40 g/L glucose and 40 g/L xylose at 100 
RPM.  200 µg/mL hygromycin was added to maintain plasmid stability.  Datapoints are the 





Figure 23 – Optimizing culture conditions for sedoheptulose production. 
Agitation speed, initial cell inoculum, and carbon source were varied to identify optimum culture conditions for producing 
sedoheptulose. The SR8 strain with the pRS42H-PHO13 vector was used in 25 mL YP media in 125 mL flasks.  200 µg/mL 
hygromycin was added to all flasks to maintain plasmid stability.  Datapoints are the average of biological duplicates with error bars 





Figure 24 – Comparing plasmid and genome-based overexpression of PHO13 for 
production of sedoheptulose. 
Both strains were cultured in 25 mL YP medium in 125 mL flasks containing 40 g/L xylose in 
addition to 40 g/L glucose, which was consumed within the first 24 hours.  200 µg/mL 
hygromycin was added to flasks with SR8 containing the pRS42H-PHO13 plasmid to maintain 






Figure 25 – Altering the pentose phosphate pathway to enhance sedoheptulose production. 
All fermentations carried out in 25 mL YP medium with 40 g/L xylose and glucose at 250 RPM.  Datapoints are the average of 






Figure 26 – Overexpression of TKL1 does not improve sedoheptulose production. 
Yields of sedoheptulose (blue) and xylulose (red) from fermentation on rich YP medium.  The 






Figure 27 – Scaling up sedoheptulose production in a 1L bioreactor. 
Initially, 40 g/L of glucose and 80 g/L of xylose were fed with periodic feeding of glucose as 
needed.  Agitation was set to 500 RPM, gas flow was set to 1.0 liters per minute, and pH was 




Table 4 – Primers used in this study. 
 
Primer name Primer Description Primer Sequence 
ΔTAL1_d_f ΔTAL1 donor forward GTAAAATACTTCTCGAACTCGTCACATATACGTGTACATAatctgagtaacgtagtccat 
ΔTAL1_d_r ΔTAL1 donor reverse AATAGAGTCAAATTACAGTGGATACCGTCCTTTTCTTCCAatggactacgttactcagat 
ΔTAL1_c_f ΔTAL1 confirm forward gcaacatcaagtcatagtc 
ΔTAL1_c_r ΔTAL1 confirm reverse atggactacgttactcagat 
M13_d_f M13 forward for insertion into 
PBN1-SBP1 region 
AATTCTATGTATACATAATATATCTATTGCTTTCTTTTCCgtaatacgactcactatagg 
M13_d_r M13 reverse for insertion into 
PBN1-SBP1 region 
ATCACAAGAAAAAGTAGTAACAAAGAGCATTATTTTTCCATTCaaacagctatgaccatg 
M13_c_f PBN1 confirmation forward GAATACTCTCTTCGAGATAAGGC 
M13_c_r SBP1 confirmation reverse CCGTCCTATTAAGAAGGTTGC 
pCCW12_TKL1_f TKL1 forward w/ pCCW12 
homology 
GAAATTAATCTTCTGTCATTCGCTTAAACACTATATCAATAAatgactcaattcactgac 
CS6_tTKL1_r tTKL1 reverse w/ CS6 homology TAATTAGGTAGACCGGGTAGATTTTTCCGTAACCTTGGTGTCatgataattagaagtgcc 
CS6_pCCW12_f pCCW12 forward with CS6 
homology 
CTCATAACCTCGAGGAGAAGTTTTTTTACCCCTCTCCACAGATCcacccatgaaccacac 
pCCW12_r pCCW12_rev TTATTGATATAGTGTTTAAGCG 
 




Table 4 – Primers used in this study (continued). 
 
Primer name Primer Description Primer Sequence 
CS6_c_f CS6 confirm forward GTCTGCCGAAATTCTGTG 
TKL1_c_r TKL1 confirm rev CTGGTGTTCTGGAACC 
pCCW12_TKL1_seq_f amplifying pCCW12-TKL1 for sequencing forward GAACCACACGGTTAGTC 
pCCW12_TKL1_seq_r amplifying pCCW12-TKL1 for sequencing reverse CATGATAATTAGAAGTGCC 
 pCCW2-TKL1_seq_1 pCCW2-TKL1 seq forward 1 CTCACCTCACTAACGCTGC 
 pCCW2-TKL1_seq_2 pCCW2-TKL1 seq forward 2 GTATCCAAGGCCAACTCAGG 
 pCCW2-TKL1_seq_3 pCCW2-TKL1 seq forward 3 ACCATTGGTTACGGTTCCTTGC 




Table 5 – Cas9 target site sequences from this study. 
Protospacer adjacent motif (PAM) sites are underlined next to the 20 base pair target site.  The 
CS6 site was previously reported as functional for gene integration (Kwak et al., 2017). 
 
Cas9 target site name Cas9 target site sequence 
PBN1/SBP1 intergenic region TTTATTTTCAATATTATACAAGG 
TAL1 deletion CAAGTTGATCGATGTTGCCGTGG 










CHAPTER 5: ENGINEERING YEAST FOR BIOSYNTHESIS OF THE 







The previous chapter presented a new method to produce the rare sugar sedoheptulose by 
directing flux from xylose assimilation into dephosphorylation of the pentose phosphate 
intermediate sedoheptulose-7-phosphate (S7P).  While there are potential utilities of 
sedoheptulose and increasing its availability can encourage further research into its health 
effects, the redirection of flux from xylose assimilation towards S7P may have additional 
metabolic engineering applications.  Beyond simple dephosphorylation into sedoheptulose, S7P 
is a gateway molecule to a huge class of cyclic compounds with a variety of uses.  After 
dephosphorylation and cyclization by an S7P cyclase, carbon flux from S7P can proceed towards 
many different metabolic fates.  In this chapter, we use the cyclic sunscreen compound gadusol 
as an example of one of the potential metabolic fates of cyclization of S7P.  We express two 
enzymes, a cyclase and a methyltransferase—oxidase, to biosynthesize gadusol in engineered 
xylose-consuming yeast strains.  By optimizing the enzyme choice and determining S-
adenosylmethionine as the limiting factor in gadusol production, we achieve a maximum 
production of around 250 mg/L gadusol from 40 g/L xylose, representing the highest titer and 
yield of gadusol produced yet using an engineered microbe.  Beyond production of gadusol, the 
results presented in this chapter have applications towards an entire class of compounds called 
mycosporine-like amino acids (MAAs).  Many MAAs are produced in several steps after 
cyclization of S7P and have various applications such as sunscreens, protection against oxidative 
stress, pigments, and photoreception.  Like sedoheptulose, production of these compounds is 
difficult and costly.  Yet, it is likely that are more as-yet undiscovered MAAs with novel 
functions and properties.  The results presented in this chapter have the potential to be applied to 
a variety of MAAs and other cyclic compounds derived from S7P.  
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5.1  Introduction 
 The previous chapter showed that production of the rare sugar sedoheptulose was 
possible using engineered xylose-consuming yeast overexpressing the phosphatase encoded by 
PHO13.  This allowed dephosphorylation of sedoheptulose-7-phosphate (S7P) into 
sedoheptulose at high yields and titers.  In addition to sedoheptulose, S7P is a gateway molecule 
to a large number of cyclic carbon molecules including mycosporine-like amino acids (MAAs) 
(Osborn, Kean, Karplus, & Mahmud, 2017).  These compounds have a variety of functions, such 
as antibiotic, medical, and even UV-absorbing sunscreens (Osborn et al., 2017). 
 In order to assess the potential of directing xylose carbon flux towards a S7P-cyclase and 
downstream product, the information from the previous chapter was applied towards the 
production of gadusol, a natural sunscreen molecule (Osborn et al., 2015). This compound was 
chosen for its relatively short biosynthetic pathway as well as its high potential utility for 
consumers. 
 Biosynthesis of gadusol from S7P occurs in only two steps.  The first step, cyclization, 
results in removal of the phosphate from S7P and generation of the cyclic 2-epi-5-epi-valiolone 
(EEV).  The second step is driven by a methyltransferase—oxidase (MtOx) enzyme recently 
characterized from zebrafish (Osborn et al., 2015).  This second step requires the cofactor S-
adenosylmethionine which functions as a methyl donor. 
 Gadusol is only one example of a large and growing number of natural products derived 
from S7P.  Among identified natural products of this class, the utilities of only a few of these 
compounds have been determined.  This information will be useful for future researchers as the 
knowledge of MAAs and seven-carbon cyclic compounds continues to grow in the coming years. 
 
5.2  Methods 
5.2.1 Plasmid and strain construction 
The pRS405 yeast vector containing a leucine marker and the pRS406 yeast vector 
containing a uracil marker were used to hold the gadusol biosynthetic genes EEVS, ValA, 
DrMtOx, and SgMtOx.  The sedoheptulose-7-phosphate cyclase genes EEVS and ValA were 
synthesized from Twist Bioscience (San Francisco, CA, USA) as synthetic gene fragments, 
including an attached yeast terminator ADH1t.  Each synthetic gene fragment and terminator was 
cloned into the pRS405 vector. Then, the GPDp yeast promoter was cloned into the vector 
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yielding the plasmids pRS405-EEVS and pRS405-ValA.  The methyltransferase—oxidase 
(MtOx) genes DrMtOx and SgMtOx were also synthesized from Twist Bioscience as synthetic 
gene fragments and cloned into the pRS406 series vectors.  Then, the yeast ADH1t terminator 
and GPDp promoter were cloned into these vectors, yielding plasmids pRS406-DrMtOx and 
pRS406-SgMtOx.  The primers used for plasmid construction can be found in Table 9. 
Two sets of gadusol-biosynthesizing strains were produced in this study.  The first set 
was created from the base strain CT2, which is a xylose-consuming quadruple auxotrophic (his- 
leu- trp- ura-) engineered yeast strain (Tsai et al., 2015).  The plasmids described above (pRS405-
EEVS, pRS405-ValA, pRS406-DrMtOx, and pRS406-SgMtOx) were transformed into the CT2 
strain and selected with minimal (SC) media lacking uracil or leucine.  The resulting strains are 
shown in Table 6. 
The second set of gadusol synthesizing strains were created from the base strain SR8 (S. 
R. Kim, Skerker, et al., 2013) using CRISPR/Cas9 genome engineering.  The plasmids described 
above (pRS405-EEVS, pRS405-ValA, pRS406-DrMtOx, and pRS406-SgMtOx) were used as 
templates in a PCR reaction to create donor DNA used to repair a Cas9 cut site.  The cut site 
target sequences are shown in Table 8.  The EEVS and ValA expression cassettes were inserted 
into the CS6 genomic integration site while the DrMtOx and SgMtOx expression cassettes were 
inserted into the CS5 genomic integration site (Kwak et al., 2017).  Cas9 was expressed in yeast 
using the plasmid pRS42N-Cas9 while a custom gRNA was expressed from the pRS42H-
CS5gRNA or pRS42H-CS6gRNA plasmids (Zhang et al., 2014). The resulting strains are shown 
in Table 7.  Additionally, one set of gadusol-synthesizing strains was created from the SR8Δtal1 
strain, which contains a deletion in the TAL1 gene.  The TAL1 gene was deleted in the SR8 strain 
using CRISPR/Cas9 genome engineering.  The Cas9 cut site is listed in Table 8 and the primers 
used for this deletion are shown in Table 9. 
 
5.2.2 Media and culture conditions 
YP media consists of 10 g/L yeast extract and 20 g/L peptone.  For selection of 
transformants, SC media was used.  SC media consists of 6.7 g/L yeast nitrogen base and 0.79 
g/L CSM (MP Biomedicals).  For fermentations, a single colony was picked and precultured in 3 
mL YP media in 15 mL culture tubes with 20 g/L glucose as a carbon source. After about 12 
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hours, cells were inoculated into the main culture.  Unless otherwise specified, cultures were 
performed in 25 mL media in 125 mL flasks at 30°C.    
 
5.2.3 Analytical methods 
Biomass was quantified as the absorbance at 600nm (OD600) using a Biomate 5 UV-
visible spectrophotometer (Fisher, NY, USA).  The concentration of glucose, xylose, 
sedoheptulose, glycerol, xylitol, and ethanol were measured using high-performance liquid 
chromatography (HPLC) (Agilent, Santa Clara, CA, USA) with a Rezex ROA-Organic Acid H+ 
(8%) column (Phenomenex Inc.).  Gadusol was measured using the absorbance at 294 nm after 
resuspending diluted supernatant into 50 mM phosphate buffer at pH7.  With an extinction 
coefficient calculated to be 21,800 M-1 cm-1, this measurement allowed quantification of gadusol 
using the equation A=εLc where A is absorbance, ε is the extinction coefficient, and c is the 
molar concentration of gadusol. 
 
5.3  Results and Discussion 
 Gadusol is biosynthesized from sedoheptulose-7-phosphate (S7P) in two steps: a 
cyclization reaction producing 2-epi-5-epi-valiolone (EEV) from S7P followed by a 
methyltransferase—oxidase reaction producing gadusol from EEV with the cofactor S-
adenosylmethionine as a methyl donor (Figure 28). For the first step, cyclization, we chose to 
express two variants: EEVS from Danio rerio and ValA from Streptomyces hygroscopicus.  
EEVS from D. rerio has previously been shown to be functional in yeast and can functionally 
participate in biosynthesis of gadusol in engineered yeast (Osborn et al., 2015).  The ValA gene 
from Streptomyces hygroscopicus encodes a sedoheptulose-7-phosphate cyclase which has been 
well characterized, including determination of its protein structure (Kean, Codding, Asamizu, 
Mahmud, & Karplus, 2014; Mahmud, Asamizu, Karplus, Kean, & Codding, 2014; Yu et al., 
2005). For the production of gadusol from EEV, the MtOx gene from D. rerio (DrMtOx) has also 
been proven functional in yeast and capable of producing gadusol in engineered yeast (Osborn et 
al., 2015).  A BLAST search revealed that this protein contained a unique motif from amino 
acids 274-282 which is not present or is significantly altered in the most closely-related variants 
available.  We thus also chose to investigate the MtOx gene from Sinocyclocheilus grahami 
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(SgMtOx), which is nearly identical to the DrMtOx gene apart from several mutations within the 
amino acid 274-282 motif. 
 These genes were synthesized and used to construct four expression vectors, with the 
EEVS and ValA gene under control of the GPDp promoter on the pRS405 integrative plasmid 
while the DrMtOx and SgMtOx genes were under control of the CCW12p promoter on the 
pRS406 integrative plasmid. Following deletion of the TAL1 gene to promote accumulation of 
S7P for the cyclization reaction in the auxotrophic xylose-consuming engineered yeast strain 
CT2Δtal1, the plasmids were then integrated into the genome (Tsai et al., 2015), yielding three 
control strains and four strains harboring the complete gadusol biosynthetic pathway (Table 6).  
These strains were then grown in 25mL YP media in 125 mL flasks with glucose and xylose as 
carbon sources and the absorbance spectra of the supernatants were analyzed with the empty-
vector CT2Δtal1-ev strain used as a blank (Figure 29).  Apart from the CT2Δtal1-ValA-SgMtOx 
strain, a unique absorbance peak maximizing near 294nm was observed in all strains.  Among 
the three remaining strains, the CT2Δtal1-ValA-DrMtOx strain produced the highest peak.  A 
maximum of roughly 90 mg/L gadusol was produced from the CT2Δtal1-ValA-DrMtOx strain 
(Figure 30). 
 Despite the highest peak being observed in the CT2Δtal1-ValA-DrMtOx strain (Figure 
31A), expression of the EEVS gene was associated with an unidentified brown coloration after 
several days of culturing and a wide absorbance peak between 320-420 nm (Figure 31B).  
Expression of the ValA gene also led to accumulation of a dark coloration and production of the 
same absorbance peak, although much less so.  This result indicates that despite having a slightly 
smaller absorbance peak, the EEVS gene functions better than ValA by producing either an 
unintended byproduct or causing accumulation and subsequent degradation of EEV into a 
colored byproduct. 
 We therefore hypothesized that the methyl donor S-adenosylmethionine may be limiting 
during gadusol production.  In order to increase the pool of available S-adenosylmethionine, we 
fed the precursor methionine at different concentrations in a fresh culture with the CT2Δtal1-
EEVS-DrMtOx strain.  This methionine feeding led to increased production of gadusol in a 
concentration-dependent manner (Figure 32).  At maximum, over 250 mg/L of gadusol was 




However, reculturing or picking a fresh colony of these CT2-based strains began yielding 
inconsistent results.  Strains which previously were observed to produce this unique absorbance 
peak attributed to gadusol would spontaneously cease production.  Additionally, the CT2Δtal1-
ValA-SgMtOx strain which failed to produce any gadusol was found to have dropped the 
SgMtOx gene upon colony PCR analysis, however also losing its uracil auxotrophy.  
Furthermore, colony PCR analysis revealed that other strains after spontaneously losing gadusol-
production capabilities had spontaneously dropped one or both genes in the gadusol biosynthesis 
pathway.  When a pRS40X vector integrates into the genome, it results in a length of DNA 
containing a non-functional auxotrophic marker, the inserted DNA sequence, and then a 
functional copy of the auxotrophic marker.  It is this possible to drop the non-functional 
auxotrophic marker and the inserted DNA sequence through homologous recombination.  
Additionally, the CT2Δtal1-based strains were consuming xylose substantially slower than the 
SR8Δtal1 strain. 
In order to bypass these problems with stability and fermentation speed, we next created 
a set of stable efficient xylose-consuming gadusol-producing strains from the base strains SR8 
and SR8Δtal1 using CRISPR/Cas9 genome editing.  An additional eight strains were constructed 
holding the EEVS, ValA, DrMtOx, and SgMtOx genes (Table 7).  These strains were then tested 
in culture tubes containing YP medium and glucose and xylose as carbon sources.  Using SR8 or 
SR8Δtal1 as a blank control for each set of four strains, an absorbance peak around 294nm could 
easily be observed.  The deletion of TAL1 clearly had a beneficial effect on gadusol production, 
leading to a much higher absorbance peak over the base strain SR8.  However, an overlapping 
peak extending to around 420 nm made quantification difficult (Figure 33).   
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Figure 28 – The gadusol biosynthesis pathway. 
Sedoheptulose-7-phosphate is cyclized into 2-epi-5-epi-valiolone (EEV) by sedoheptulose-7-phosphate cyclase encoded by the ValA 
or EEVS gene.  Then, a methyltransferase—oxidase enzyme encoded by DrMtOx or SgMtOx converts EEV into gadusol with use of 





Figure 29 – Expression of the gadusol biosynthesis pathway in the xylose-consuming yeast 
strain CT2. 
CT2 containing either pRS405-EEVS (top) or pRS405-ValA (bottom) together with pRS406-
DrMtOx (left) or pRS406-SgMtOx (right).  Strains were cultured in 5 mL YP media with 40 g/L 
glucose and 40 g/L xylose in sterile 15 mL culture tubes at 250 RPM.  Strain instability caused 
the lack of gadusol production observed in the ValA + SgMtOx strain. Supernatant from the 






Figure 30 – Fermentation profile of gadusol synthesizing strains. 
Gadusol concentration was calculated based on the absorbance at 294 nm as shown in Figure 29.  
Strains were cultured in 25 mL YP media in 125 mL flasks at 250 RPM and 30°C.  Data points 





Figure 31 – Absorbance spectrum of gadusol-producing strains and unidentified color 
change. 
(A) Absorbance spectrum of the CT2Δtal1-EEVS-DrMtOx and CT2Δtal1-ValA-DrMtOx 
strains.  (B) Unidentified color change apparent in supernatant of gadusol-synthesizing strains.  





Figure 32 – Feeding of methionine enhances gadusol production. 
Strain CT2-EEVS-DrMtOx was cultured in 5 mL SC defined media with 40 g/L glucose and 40 





Figure 33 – Absorbance spectrum analysis of supernatants produced by SR8-based strains containing the gadusol biosynthetic 
pathway. 
Due to strain instability observed in the CT2-based gadusol production strains, the gadusol biosynthesis pathway was introduced into 
the SR8 base strain using CRISPR genome editing instead of auxotrophic selection plasmids.  Strains were cultured in 5 mL YP media 
with 40 g/L glucose and 40 g/L xylose in sterile 15 mL culture tubes at 250 RPM.  Gadusol production was measured by absorbance 




Table 6 – Strains created in this study from the CT2 base strain. 
  
Strain name LEU plasmid URA plasmid 
CT2 (Tsai et al., 2015) none none 
CT2Δtal1 none none 
CT2Δtal1-ev pRS405 pRS406 
CT2Δtal1-EEVS pRS405-EEVS pRS406 
CT2Δtal1-EEVS-DrMtOx pRS405-EEVS pRS406-DrMtOx 
CT2Δtal1-EEVS-SgMtOx pRS405-EEVS pRS406-SgMtOx 
CT2Δtal1-ValA pRS405-ValA pRS406 
CT2Δtal1-ValA-DrMtOx pRS405-ValA pRS406-DrMtOx 
CT2Δtal1-ValA-SgMtOx pRS405-ValA pRS406-SgMtOx 
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Table 7 – Strains created in this study from the SR8 base strain. 
 
  
Strain name Description 
SR8  (S. R. Kim, Skerker, et al., 2013) 
SR8-ED GPDp-EEVS-adh1t in CS6 region / CCW12p-DrMtOx-adh1t in CS5 region 
SR8-ES GPDp-EEVS-adh1t in CS6 region / CCW12p-SgMtOx-adh1t in CS5 region 
SR8-VD GPDp-ValA-adh1t in CS6 region / CCW12p-DrMtOx-adh1t in CS5 region 
SR8-VS GPDp-ValA-adh1t in CS6 region / CCW12p-SgMtOx-adh1t in CS5 region 
SR8Δtal1 SR8 with a deletion in the TAL1 gene 
SR8Δtal1-ED GPDp-EEVS-adh1t in CS6 region / CCW12p-DrMtOx-adh1t in CS5 region 
SR8Δtal1-ES GPDp-EEVS-adh1t in CS6 region / CCW12p-SgMtOx-adh1t in CS5 region 
SR8Δtal1-VD GPDp-ValA-adh1t in CS6 region / CCW12p-DrMtOx-adh1t in CS5 region 
SR8Δtal1-VS GPDp-ValA-adh1t in CS6 region / CCW12p-SgMtOx-adh1t in CS5 region 
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Table 8 – Cas9 target sites used in this study. 
Protospacer adjacent motif (PAM) sites are underlined next to the 20 base pair target site.  The 
CS5 and CS6 sites were previously reported as functional for gene integration (Kwak et al., 
2017). 
 
Cas9 target site name Cas9 target site sequence 
CS5 integration site (Kwak et al., 2017) CTGGTAGTTGCACAGAAAGAAGG 
CS6 integration site (Kwak et al., 2017) GATACTTATCATTAAGAAAATGG 
TAL1 deletion CAAGTTGATCGATGTTGCCGTGG 
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Table 9 – Primers used in this study 
 






SalI-CCW12p forward acgttacgGTCGACcacccatgaaccacacg 
Spe1-CCW12p reverse ctgagtacACTAGTttattgatatagtgtttaagcgaatgac 
NotI-adh1t forward gtacgtacGCGGCCGCgcgaatttcttatgatttatga 









ΔTAL1 donor forward GTAAAATACTTCTCGAACTCGTCACATATACGTGTACATAatctgagtaacgtagtccat 
ΔTAL1 donor reverse AATAGAGTCAAATTACAGTGGATACCGTCCTTTTCTTCCAatggactacgttactcagat 
ΔTAL1 confirm forward gcaacatcaagtcatagtc 







CHAPTER 6: LACTIC ACID PRODUCTION IN YEAST THROUGH FLUX 







Significant amounts of research have focused on the production of lactic acid using 
engineered Saccharomyces cerevisiae.  Most studies have eliminated the production of ethanol 
by deleting the PDC1, PDC5, and PDC6 genes encoding pyruvate decarboxylase isoforms.  
However, deletion of these genes reduces the production of acetaldehyde, an important precursor 
of the versatile metabolite acetyl-CoA.  Consequently, this strategy results in an engineered 
strain which struggles to complete a fermentation.  A previous report has shown that alternative 
carbon sources such as xylose and cellobiose can allow enhanced lactic acid yields without 
deletion of the important PDC genes.  In this chapter, a greater understanding is sought as to why 
these alternative carbon sources lead to increased lactic acid yields without removal of the 
pyruvate decarboxylase enzymes.  By modulating glycolytic flux in a strain carrying a lactic acid 
dehydrogenase, the high lactic acid yields observed from cellobiose cultures are recreated solely 
by slowing the rate of glucose consumption.  However, this methodology is unable to match the 
yields of lactic acid observed from xylose, indicating the presence of additional regulatory or 
physiological factors during xylose metabolism which favor the production of lactic acid.  All 
this information is finally applied to a strain capable of simultaneously consuming glucose and 
xylose.  By enabling simultaneous rather than sequential consumption of glucose/xylose 
mixtures, lactic acid production is increased to approximately 17 g/L from 12 g/L observed 
during sequential consumption of sugars.  Ethanol production is also reduced from the 8 g/L 
observed during sequential consumption of sugars to the 4 g/L generated during simultaneous 
co-fermentation of xylose and glucose.  
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6.1  Introduction 
Transgenic expression of the fungal Rhizopus oryzae LdhA can allow production of lactic 
acid (Liaud et al., 2015; Skory, 2003).  Engineered S. cerevisiae carrying this LdhA gene are also 
able to convert sugars into lactic acid (Skory, 2003).  In engineered yeast strains carrying the R. 
oryzae LdhA, it has previously been reported that culturing cells on xylose or cellobiose leads to 
higher yields of lactic acid and reduced ethanol production (Turner et al., 2018, 2015, 2016). 
Despite this observation, an exact molecular mechanism explaining the carbon source 
effect on lactic acid production remains unknown.  It has been shown that the carboxylic acid 
transporters encoded by JEN1 and ADY2 are capable of lactic acid transport (Casal, Queirós, 
Talaia, Ribas, & Paiva, 2016; Pacheco et al., 2012).  However, removal of all known carboxylic 
acid transporters still leaves open the possibility of lactic acid transport in S. cerevisiae (Mans et 
al., 2017).  The major lactic acid transporter encoded by JEN1 is degraded and downregulated in 
the presence of glucose (Paiva et al., 2009), which may partially explain this glucose effect, but 
still much remains unknown. 
This chapter is focused on gaining additional information about the mechanisms causing 
enhanced lactic acid yields from the alternative carbon sources xylose and cellobiose.  By 
investigating the role of glycolytic flux, we are able to recreate the enhanced lactic acid yields 
from cellobiose while feeding only glucose. 
This information is then used to generate these high lactic acid yields when culturing 
yeasts on a mixture of glucose and xylose.  Compared to a standard engineered xylose-
consuming yeast, our mutant SR8#22 yeast strain (Stephan Lane, Xu, et al., 2018) capable of 
simultaneous uptake of glucose and xylose is shown to generate increased lactic acid yields and 
titers. 
 
6.2  Methods 
6.2.1 Strains, media recipes and culture conditions 
Preculture was performed in 5 mL of YP medium (10 g/L yeast extract, 20 g/L Bacto 
peptone) aerobically at 30°C for 36 hours with 40 g/L of glucose as a carbon source.  When 
using the D452-iH1L and D452-iH2L strains, preculture was performed in 5 mL of YP medium 
aerobically at 30°C for 36 hours with 40 g/L of galactose along with 0, 2, 4, 6, 8, 10, or 12 
µg/mL of doxycycline. Fermentation experiments were performed in 125 mL flasks containing 
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25 mL YP medium at 30°C and 100 rpm, with initial carbon sources indicated in fermentation 
profiles. All fermentations contained 20 g/L CaCO3 to maintain pH near neutral levels.  The 
strains used in this study can be found in Table 10.  Doxycycline was added to fermentations 
with the D452-iH1L and D452-iH2L strains to final concentrations of 0, 2, 4, 6, 8, 10, and 12 
µg/mL of fermentation medium to control expression of hexokinase and the overall consumption 
rate of glucose. 
 
6.2.2 Genetic techniques 
 Standard restriction digestion and molecular cloning techniques were employed for 
plasmid creation (Lessard, 2013; Wood, 2003).  For doxycycline induction experiments, the 
rtTA(S2) variant (Urlinger et al., 2000) was synthesized from IDT as a gBlock.  Two integrative 
plasmids were created to house the synthetic transactivator rtTA(S2) (Urlinger et al., 2000) and 
the TetO7-driven target gene as described previously (Stephan Lane, Xu, et al., 2018). To create 
SR8 and EJ4 strains expressing a single copy of LdhA, CRISPR genome editing was used to 
integrate a pPGK1-LdhA-tPGK1 expression cassette into the PBN1-SBP1 intergenic region at 
the target site TTTATTTTCAATATTATACAAGG.   
 
6.2.3 Analytic methods 
Sugar, ethanol, and lactic acid concentrations were quantified by the Rezex ROA-
Organic Acid H+ (8%) column (Phenomenex Inc., Torrance, CA).  Biomass was quantified by 
measuring optical density (OD) at 600nm with a UV-visible spectrophotometer (Biomate 5, 
Fisher, NY). 
 
6.3  Results and Discussion 
The lactic acid dehydrogenase gene LdhA from Rhizopus oryzae was introduced into the 
parental D452, xylose-consuming SR8, and cellobiose-consuming EJ4 strain to allow production 
of lactic acid.  The resulting strains were named D452L, SR8L, and EJ4L, respectively.  These 
three strains were then cultured in 25 mL YP media in 125mL flasks with 20 g/L CaCO3 to 
maintain pH stability.  The D452L strain was cultured on glucose, the SR8L strain on xylose, 
and the EJ4L strain on cellobiose.  Although these are three different strains, they are all 
comparable as the SR8 strain is derived from D452, and the EJ4 strain is derived from SR8. 
97 
 
The carbon source led to a clear difference in lactic acid yield.  Glucose cultures 
produced ethanol almost entirely, cellobiose cultures produced slightly more lactic acid than 
ethanol, and xylose cultures produced almost entirely lactic acid (Figure 34).  Xylose was clearly 
the superior carbon source when aiming to produce lactic acid, leading to a yield of 
approximately 0.5 g lactic acid / g xylose.  
One clear difference between these strains is the rate of sugar consumption.  The glucose 
culture rapidly converts glucose into ethanol and small amounts of lactic acid.  Cellobiose and 
xylose cultures take significantly longer for complete conversion of sugars.  It is possible that 
sugar uptake flux could impact whether lactic acid or ethanol becomes the predominant product.  
In order to test this hypothesis, we created a set of strains with external control over the 
glycolytic flux.  This was performed by deleting all hexokinases in D452, leading to the strain 
D452∆hxk0 which is unable to consume glucose.  Then, the synthetic transactivator rtTA(S2) 
(Urlinger et al., 2000) was introduced follow by reintroduction of hexokinase expression under 
control of the rtTA(S2)-controlled TetO7 promoter.  As a result, adding doxycycline allowed 
increased hexokinase expression in a titratable manner.  In a previous publication, we have 
shown that this technique allows complete control over the glucose consumption rate (Stephan 
Lane, Xu, et al., 2018).  We created two sets of strains from this, one with controllable 
expression of HXK1 and the other with controllable expression of HXK2.  We next introduced R. 
oryzae LdhA into these strains, yielding the strains D452 iH1L and D452 iH2L. 
 These strains were then cultured in 25 mL YP media in 125 mL flasks with 20 g/L 
CaCO3 and various amounts of doxycycline.  The yields of lactic acid and ethanol produced were 
then calculated from mid-exponential phase timepoints.  There was a clear relationship between 
glycolytic flux and product (Figure 35).  As sugar consumption rate slowed, the strains tended to 
produce more ethanol.  In contrast, the rapidly-consuming yeast strains produced predominantly 
ethanol.  The control D452L strain exhibited the fastest consumption rate due to possessing all its 
original hexokinases under their native promoters and regulation, and this strain yielded the 
highest amount of ethanol and least amount of lactic acid among all tested strains. 
To determine whether different fluxes played a role in the increased yield of lactic acid 
from different carbon sources, we then calculated the product yields from the EJ4L and SR8L 
strains consuming cellobiose and xylose, respectively, during mid-exponential phase and plotted 
the result on this same graph (Figure 36).  Cellobiose cultures fit entirely on the same trend as 
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the glucose cultures.  Cellobiose was consumed slower than all the glucose-consuming strains 
and exhibited reduced ethanol yields and near-equal yields of lactic acid.  The SR8L strain 
exhibited the lowest sugar consumption rate among all strains tested.  However, it did not fit on 
the trend produced by glucose and cellobiose consumption.  Instead, the SR8L strain consuming 
xylose produced nearly the theoretical maximum yield of lactic acid during mid-exponential 
phase along with nearly zero ethanol production.  From this result, we can say that reduced 
glycolytic flux from cellobiose can explain the enhanced lactic acid yields, but that reduced 
carbon flux cannot entirely explain the phenomenal yields of lactic acid from cellobiose.  There 
must be some other physiological mechanism or factors that lead to enhanced lactic acid yields 
from engineered yeast strains cultured on xylose.  It is possible that lactic acid transporters are 
expressed higher in xylose conditions than in glucose. 
Consumption of glucose/xylose mixtures by engineered yeast usually results in two 
stages: rapid consumption of glucose followed by slow xylose assimilation.  However, a prior 
report has shown that reduced glycolytic flux allows simultaneous uptake of both glucose and 
xylose (Stephan Lane, Xu, et al., 2018).  This coupled with the information shown here—that 
xylose is a superior carbon source for lactic acid production and that slow glucose consumption 
is better than fast glucose consumption for yielding lactic acid—led us to hypothesize that 
cofermentation of glucose and xylose by reducing glycolytic flux may also lead to enhanced 
lactic acid yields. 
Therefore, the R. oryzae LdhA gene was introduced into the glucose/xylose cofermenting 
engineered yeast strain SR8#22 (Stephan Lane, Xu, et al., 2018).  Then, the SR8 strain and the 
SR8#22 strain were compared in fermentations of glucose, xylose, and a mixture of 
glucose/xylose (Figure 37).  Similar to the results above, the SR8L strain cultured on glucose 
produced primarily ethanol with small amounts of lactic acid.  The slow-consuming SR8#22 
strain cultured on glucose instead yielded primarily lactic acid.  When cultured on xylose, the 
two strains performed similarly.  Both finished xylose consumption in similar amounts of time 
and yielded predominantly lactic acid.  When cultured in a mixture of glucose and xylose, the 
SR8L strain rapidly consumed glucose, produced ethanol, and then consumed xylose and yielded 
primarily lactic acid.  At the end of the fermentation, the SR8L strain had produced about 8 g/L 
ethanol and 12 g/L lactic acid.  The SR8#22 strain simultaneously consumed glucose and xylose 
and primarily produced lactic acid.  At the end of fermentation, the SR8#22 strain led to 
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accumulation of 17 g/L lactic acid and 4 g/L ethanol.  These results demonstrated another clear 
benefit of reduced glycolytic flux when aiming to produce lactic acid.  In addition to allowing 
greater yields of lactic acid from glucose, the same strategy also enables simultaneous co-








Figure 34 – Carbon source affects lactic acid yield. 
Fermentation of the D452L strain on glucose (left), the EJ4L strain on cellobiose (middle left), and the SR8L strain on xylose (middle 
right) along with yields from each fermentation (right).  Fermentations were performed in 25 mL YP media in 125 mL flasks with 20 





Figure 35 – Glycolytic flux impacts lactic acid yield. 
The square datapoint indicates the control strain D452L while the downward facing arrow 
represents the inducible-HXK1 strain and the upward facing arrow represents the inducible-
HXK2 strain.  All strains were expressing the LdhA gene from Rhizopus oryzae.  Black 
datapoints represent ethanol yield while red datapoints represent lactic acid yields.  Yields were 
calculated during mid-exponential phase.  Datapoints are the average of duplicates with standard 





Figure 36 – Glycolytic flux can explain enhanced lactic acid yields from cellobiose, but not 
xylose. 
The graph from Figure 35 was replotted with the SR8L strain using xylose (diamond) and the 
EJ4L strain using cellobiose (star). Black datapoints represent ethanol yield while red datapoints 
represent lactic acid yields.  Yields were calculated during mid-exponential phase.  Datapoints 





Figure 37 – Cofermentation of glucose and xylose enhances lactic acid yields. 
The SR8L strain (top) and the SR8#22L strain (bottom) cultured on glucose (left), xylose 
(middle), and a mixture of glucose/xylose (right). Fermentations were performed in 25 mL YP 
media in 125 mL flasks with 20 g/L CaCO3 at 100 RPM and 30°C.  Data points are the average 




Table 10 – Strains used in this study.
Strain Description Reference 
SR8 Xylose fermenting Saccharomyces cerevisiae  (S. R. Kim, Skerker, et al., 2013) 
SR8L SR8 / pPGK1-LdhA-tPGK1 in PBN1-SBP1 intergenic region This study 
EJ4 Cellobiose and xylose fermenting Saccharomyces cerevisiae (Wei, Oh, Million, Cate, & Jin, 2015) 
EJ4L EJ4 / pPGK1-LdhA-tPGK1 in PBN1-SBP1 intergenic region This study 
D452 ∆his ∆leu ∆ura (Hosaka, Nikawa, Kodaki, & Yamashita, 1992) 
D452L D452 / pRS405-LdhA This study 
D452∆hxk0 D452 ∆hxk1 ∆hxk2 ∆glk1::pMYO2-rtTA(s2) This study 
D452-iH1L D452∆hxk0 /pRS403-iHXK1 / pRS405-LdhA This study 
D452-iH2L D452∆hxk0 / pRS403-iHXK2 / pRS405-LdhA This study 
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CHAPTER 7: CONCLUDING REMARKS 
 
Many researchers over the past three decades have endeavored to develop yeast strains 
capable of efficient production of ethanol from xylose.  With this narrow-sighted goal, many 
hidden benefits of xylose metabolism have remained unnoticed.  However, using xylose as a 
carbon source has been shown to provide unique benefits when aiming to produce a variety of 
value-added bioproducts (Table 3).  Employing engineered yeast to produce the low-calorie 
sweetener xylitol, which is created in only a single enzymatic reaction from xylose, has been the 
focus of many published research articles (Guirimand et al., 2016; A. B. Kogje & Ghosalkar, 
2017; A. Kogje & Ghosalkar, 2016; Stephan Lane, Xu, et al., 2018; Zhe Li et al., 2013; E. J. Oh 
et al., 2013).  Beyond ethanol, xylose has also been employed as a carbon source to produce the 
higher alcohols 2,3-butanediol, 1-hexadecanol, and isobutanol (Brat & Boles, 2013; Brat, Boles, 
& Wiedemann, 2009; Guo et al., 2016; S. J. Kim et al., 2014; Lian et al., 2014; Nan et al., 2014).  
Isoprenoids such as squalene and amorphadiene as well as the polyamine spermidine also have 
been produced from xylose and found to be produced at higher yields and titers than from 
glucose (S. K. Kim et al., 2017; Kwak et al., 2017).  Xylose has also been used as a carbon 
source for the production of the acids poly-3-D-hydroxybutyrate and 3-hydroxypropionate, 
which are useful in creating biopolymers (de las Heras et al., 2016; Kildegaard et al., 2015; 
Sandström et al., 2015).  In total, the knowledge of the benefits of xylose metabolism for 
production of non-ethanol compounds in engineered yeast has substantially grown over the last 
five years and continues to expand. 
Here, I have grown this base of knowledge by using xylose to produce a variety of high-
value compounds.  Isobutanol was produced up to a maximum of 2.6 g/L in both a flask and a 
bioreactor, surpassing the prior reports of isobutanol production from xylose (Brat & Boles, 
2013) (Figures 17 and 18).  Production of lactic acid was also explored.  Although prior work 
has observed the maximizing effect xylose has on the yield of lactic acid, an explanation has not 
yet been provided.  The work presented here partially explains the enhanced yields of lactic acid 
from xylose as resulting from lower overall carbon flux (Figure 36).  Finally, I also used 
engineered yeast consuming xylose to produce sedoheptulose and the sunscreen compound 
gadusol.  Sedoheptulose had never been produced using modern metabolic engineering 
techniques and my efforts led to production of up to 25 grams sedoheptulose in a 1L bioreactor 
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with a maximal yield of 0.4 g sedoheptulose / g xylose in a flask (Figures 25 and 27).   Although 
gadusol has been produced previously using engineered yeast, the efforts presented here are the 
first published attempt to use xylose as a carbon source to produce this eight-carbon sunscreen 
molecule.  The work here led to over 250 mg/L gadusol accumulation and identified the limiting 
step of gadusol biosynthesis as the supply of the methyl donor s-adenosylmethionine (Figure 32). 
Here, I have reviewed the currently published progress and contributed substantially to 
the body of research regarding the biotransformation of xylose into high-value products using 
engineered S. cerevisiae.  The unique benefits of xylose metabolism for producing non-ethanol 
target molecules have been demonstrated and stressed here repeatedly and can be anticipated to 
continue to grow in the years to come.  However, there is more to be gained from the information 
presented here than only that xylose may be a good choice of carbon source when producing a 
value-added product using engineered yeast. 
 Instead, the physiological changes present during xylose metabolism should be explored. 
With a deeper understanding of the exact physiological changes during xylose metabolism, these 
same physiological and regulatory mechanisms could be implemented in cells consuming other 
carbon sources, such as sucrose, glucose, and fructose, which are cheaper and more abundant 
than xylose.  In the future, using xylose as a carbon source for certain value-added products may 
not be economically viable.  But, with enough research, understanding the molecular causes 
behind xylose metabolism’s ability to produce value-added products at high yields and titers may 
allow increased yields from cheaper and more economical carbon sources.   
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